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Summary 
Personality disorders (PDs) affect functional impairment, and the personal burden of the 
disease and costs associated with the disorder are considerable. Although the last years well-
designed studies leads to treatment optimism, evidence based knowledge regarding optimal 
format and length of treatment for the wide range of PDs seen in clinical practice is still 
lacking. The two formats of most interest with respect to both effectiveness and costs might 
be outpatient individual psychotherapy and various forms of day hospital treatments. The 
lack of valid assessments measuring dimensional aspects of core PD pathology has been a 
limitation in most former efficacy studies for patients with PDs. The Severity Indices for 
Personal Problems (SIPP-118) is such an instrument. Thus, this thesis has two main aims; 1) 
evaluating the validity of the Norwegian version of the SIPP-118, and 2) comparing two 
treatment modalities regarding clinical effect and costs. 
The Ullevål Personality Project (UPP) is a randomized controlled study (RCT) comparing 
day hospital treatment followed by combined psychotherapy (CP) with outpatient individual 
treatment (OIP) for patients with PDs (N=114). In paper I the data from the Norwegian 
translation of the SIPP-118 was compared with two Dutch samples and relevant clinical 
measures. In paper II and III, the short-term and long-term efficacy of CP and OIP was 
compared through extensive assessment of the patients’ symptoms, relational functioning, 
psychosocial functioning and personality pathology at the 8 and 18 months follow-up.  In 
paper IV, the health utilization costs before and during the two treatments were compared.  
The cross-national validity study of the SIPP-118 showed adequate psychometric properties 
at the facet level and seems promising as a measure of PD core pathology. Future studies 
should investigate the instruments ability to distinguish between axis I and axis II pathology 
and its sensitivity to change. The main results from the two efficacy studies were that there 
were no differences in change between CP and OIP. This challenges the notion that 
extensive and structured day hospital treatment models are more efficient than outpatient 
individual treatment for patients with PDs. The analysis of subgroups showed no indication 
that the initial day hospital treatment was better for the most severely disturbed patients. 
Finally, there was no difference in total costs for patients in CP and OIP as the higher 
treatment costs in CP were compensated by a reduction in the use of additional health 
services. Future studies should comprise larger samples of patients and the research should 
be supplemented with process studies exploring individual and non-linear changes, as well 
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as predictors of change.
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1. Introduction 
Personality disorders (PDs) are complex disorders leading to significant distress and 
impairment for the individuals affected. There has been a growing literature on treatment 
relevant theories for PDs, but there is still a lack of knowledge regarding efficacy of various 
treatments and treatment modalities for PDs, the assessment of PDs, cost-effectiveness of 
PD treatments, and efficacious factors in the processes towards change. The Ullevål 
Personality Project (UPP) is a randomized controlled trial (RCT) addressing some of these 
questions. This thesis is a part of the UPP and focus specifically on the validation of one 
specific instrument assessing PDs, short-term and long-term efficacy of two modalities of 
treatment for PDs, and the health utilization costs during these treatments. The results from 
the UPP could be highly relevant for clinical work with patients with PDs, as well as in 
health political decision making. 
Measuring a problem usually involves measuring incidence and prevalence. The intention 
beyond these measurements is to define the populations at risk and adopt indicators that 
correspond to the problem definition. Prevalence estimates for PDs in the community from 
five studies during the late 1980’s and early 1990’s range between 6% and 23% (Torgersen, 
1995). A later review of community surveys reported a prevalence of 4.4% - 13% (Coid, 
2003). Analyses based on the Australian National Survey of Mental Health and Wellbeing, 
estimated a lifetime prevalence of PD of 6.5% (Jackson & Burgess, 2000). Data from the 
43093 participants in the American 2001 to 2002 National Epidemiological Survey on 
Alcohol and Related Conditions showed PD prevalence between 13.6% and 19.7% (Dawson 
et al., 2005). Data from Nordic countries are sparse, but in a Swedish sample of 1000 adults 
from Gotland, a PD prevalence of 11.1 % were reported (Ekselius et al., 2001). In a 
Norwegian population of 2054 participants ranging from 18-65 years of age a prevalence of 
13.4% were estimated (Torgersen et al., 2001). The prevalence estimates of single disorders 
in the surveys reported above varies between 0% and 7.9%. Cross cultural differences have 
been pointed out, and one study shows that the prevalence of Avoidant PD (APD) in 
Norway was two times the usual findings in other studies. Schizoid PD (SPD) and Paranoid 
PDs (PPD) were also more common, and Borderline PD (BPD) less common than reported 
from studies in other countries (Torgersen et al., 2001).  
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For clinical practice and treatment the prevalence of PDs in clinical populations are of 
importance because of their association with the duration, recurrence, outcome of 
psychotherapeutic and pharmacological approaches (Bender et al., 2001; Smith & 
Benjamin, 2002). One large study found that out of 859 psychiatric outpatients 31% (45% 
including PD NOS) were diagnosed with at least one PD (Zimmerman et al., 2005) while 
other studies have shown prevalence ranging from 11% to 75% (Melberg et al., 2003; 
Oldham et al., 1995). According to Gråwe and colleagues, approximately 15% of patients 
treated by Norwegian private practitioners generally receive a PD diagnosis (Gråwe et al., 
2005), probably indicating an under diagnosing of PDs at private practitioners in Norway. 
There is of course a heterogeneity regarding severity and impairment for persons with PDs. 
Some individuals with PDs may live well with their disorders while others with more severe 
impairment may need repeatedly long-term hospitalisation. The most common PDs in 
psychotherapeutic settings are BPD, APD and NOS, while patients with other PDs such as 
antisocial PD and schizotypal PD are more often found in prisons or inpatient psychiatric 
hospitals (Coid et al., 2006). The issue of severity and type of treatment that is most 
effective for the various PDs is still relatively unexplored. The above mentioned issues will 
be approached in this thesis, both through the validation of an assessment of severity and in 
the discussion of efficacy of treatments. 
The general diagnostic criteria for a PD are “an enduring pattern of inner experience and 
behaviour that deviates markedly from the individual’s culture” (see table 1). This pattern is 
manifested in two or more of the following areas: cognition, affectivity, interpersonal 
functioning or impulse control (American Psychiatric Association, 1994, p. 633). While 
remembering the large heterogeneity in the PD patient group, PDs may affect the 
functioning and increase distress in nearly every realm of concern. The disorder affects the 
patients’ self-experience, cognitive function and social and occupational functioning. In 
addition, patients with PDs exhibit higher medical health service utilization, are exposed to 
more violence, and may respond poorer to both somatic and psychiatric treatment. As a 
group, PD patients also display more symptom disorders as anxiety, mood disorders, 
suicidality, eating disorders, and drug and alcohol abuse than non-PD patients (Smith & 
Benjamin, 2002).  
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Table 1: The general diagnostic criteria for a Personality Disorder (DSM-IV, p. 633) 
A. An enduring pattern of inner experience and behaviour that deviates markedly from 
the expectations of the individual’s culture. This pattern is manifested in two (or 
more) of the following areas:  
(1) Cognition (i.e., ways of perceiving and interpreting self, other people, and events) 
(2) Affectivity (i.e., the range, intensity, lability, and appropriateness of emotional 
response) 
(3) Interpersonal functioning 
(4) Impulse control 
B. The enduring pattern is inflexible and pervasive across a broad range of personal and 
social situations. 
C. The enduring pattern leads to clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. 
D. The pattern is stable and of long duration and its onset can be traced back at least to 
adolescence or early adulthood. 
E. The enduring pattern is not better accounted for as manifestation or consequence of 
another mental disorder. 
F. The enduring pattern is not due to the direct physiological effects of a substance (e.g., 
a drug of abuse, a medication) or a general medical condition (e.g., head trauma). 
 
 
There is a common use of the medical term “comorbidity” to describe the co-variation 
among disorders although our understanding of mental disorder has not yet reached the level 
where we can describe the disorders as truly distinct. Hence, the recently more used term 
co-occurrence will be used (Krueger, 2005). Various factors will affect rates of co-
occurrence: a) the time frame of the study, b) the sample in question, c) diagnostic methods 
used, d) criteria overlap, and e) cut-off criteria (Clark et al., 1995). Taken these factors into 
account, the independence of axis I and axis II diagnoses has been evaluated using odds 
ratio statistic. As shown in a thorough review by Dolan-Sewell and colleagues (Dolan-
Sewell et al., 2001) axis I and axis II disorders tend to co-occur at greater than chance 
levels. They concluded that “having an axis II disorder appears to place the patient at risk 
for an axis I disorder and vice versa” (p. 99). They found in their review that nearly three 
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quarters of the patients with an axis II disorder also had a present axis I disorder. The issue 
of co-occurrence between axis I and axis II disorders is important for the assessment of PDs 
as well as for clinical work, especially regarding diagnosis specific treatment. This issue 
will be discussed further in this thesis. 
Regarding axis II/axis II co-occurrence an epidemiological survey in a very large sample 
(N=43093) found a high degree of co-occurrence among the different PD diagnoses (Grant 
et al., 2005). Diagnoses within each cluster were significantly associated with each other as 
were some diagnoses across clusters, especially avoidant PD and dependent PD. These co-
occurrences may indicate that each of the PD diagnoses may be alternative manifestations of 
the same underlying disease process, or core pathology.  
1.1 Treatment of personality disorders 
Personality pathology and the problems associated with it have been recognised long before 
PDs were formally diagnosed as it is today. Already in the 19th century disorders which 
today would be described as character pathology or PDs, were addressed by theories and 
treatments (e.g. Breuer, Freud etc.). The view of personality disorders as inflexible, 
pervasive, of long duration, and with early onset has been implicit throughout the diagnostic 
manuals. In DSM-III the personality disorders were separated from symptom disorders in 
the new multi-axial system. In the revisions made according to research and professional 
feedback, a set of general diagnostic criteria underscoring the chronic qualities of PDs were 
introduced (see Table 1: DSM-IV general criteria). A pessimistic view on PDs as chronic 
disorders resistant to change was supported by clinical research. One early review of 26 
studies found in the literature, mainly inpatient treatment, found that only a very small 
amount of PD patients showed remission over a 15 year period (Perry, 1993). One possible 
explanation for the common view on PD as a chronic condition is of course the definition in 
the diagnostic manuals. But methodical difficulties such as deciding PD diagnoses 
retrospectively based on old clinical journals, and the use of poorly validated measures of 
change might have influenced the results in a negative way (Perry, 1993). Such a 
pessimistic view might turn into a self-fulfilling prophecy where neither clinicians nor 
patients believe in change, and thus no change will happen (Verheul, 2006). When 
comparing the lack of change found in the early studies with more recent studies showing a 
natural course of remission in PD pathology (Perry et al., 1999), one might also speculate if  
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there was an earlier inappropriate treatment practice leading to iatrogenic effects (Fonagy & 
Bateman, 2006).  
In the late 1990’s there was a growing clinical optimism as a set of studies showed good 
effects of treatment. The review by Perry et al. (Perry et al., 1999) concluded that 
“psychotherapy is an effective treatment for personality disorders and may be associated 
with up to a sevenfold faster rate of recovery in comparison with the natural history of 
disorders” (p.1312).  In addition, Dialectic Behavioural Therapy (DBT) was presented as a 
new highly structured treatment specifically designed for symptom improvement in BPD 
patients. In an early RCT they reported that psychotherapy, meaning the DBT model, was 
an effective treatment for PDs (Linehan et al., 1993). This was followed by other studies 
showing that symptomatic prognosis was better than previously recognised (Zanarini et al., 
2003). In later years, the research on PD treatments has increased tremendously, especially 
concerning BPD, and the increasingly positive results have led to treatment optimism. On 
the other hand, most studies have suffered from methodological limitations not allowing 
firm conclusions from single studies or comparisons across studies (Davidson et al., 2006b). 
There are numerous theories of PDs based on different concepts and understandings of 
psychological development, ranging from evolutionary and cognitive concepts, through 
interpersonal and attachment approaches, to psychoanalytical theories (Lenzenweger & 
Clarkin, 2005). Even though the development in the field seems to focus on manualized and 
specialised treatment programs based on some of these specific theories, psychodynamic 
outpatient individual psychotherapy is still probably the most common treatment for PD 
patients. Studies in this area are scarce. There is a need for studies addressing the most 
usually offered PD treatments, taking into account the need for comparison between studies, 
and at the same time meeting the methodological requirements for studying 
psychotherapeutic change. The studies reported in this thesis address many of these issues.  
1.2 Effectiveness of treatment 
The number of psychotherapy studies on PD treatment has increased the last decades. In 
1999 Perry and colleagues (Perry et al., 1999) located 15 studies reporting pre-treatment to 
post-treatment effects, including three randomized controlled trials (RCTs). Their 
conclusion was that psychotherapy is an effective treatment for PDs and may be associated 
with a much faster recovery rate in comparison with the natural history of the disorder. Two 
years later, with an approach comparing cognitive and dynamic therapy, Leichsenring and 
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Leibing (Leichsenring & Leibing, 2003a) identified 25 studies carried out from 1974 to 
2001. They concluded that both cognitive and psychodynamic therapies are effective 
treatments of PDs. Both reviews point to the limitation in the limited number of studies 
available, and underlines the need for examining specific forms of psychotherapy for 
specific types of PDs. Bateman and Fonagy (Bateman & Fonagy, 2000) relies mainly on 
cohort studies when they conclude that evidence do not suggest superiority of one type of 
therapy over the other, nor which type or modality of treatment the patients with different 
PD diagnoses should be offered. They suggest randomized controlled design studies (RCTs) 
testing long-term, integrated, and theoretically coherent treatment modalities to enhance 
knowledge in the field.  
For the current thesis a literature search of studies published between 1974 and 2007 in 
Medline, Psychinfo, major textbooks and journal articles was performed. The search 
revealed 21 RCTs where PD pathology was the main focus of treatment. Most of the studies 
focused on individual therapy and were concentrated on the treatment of BPD. Today, the 
most elaborated and structured treatment models accessible for research are Transference 
focused psychotherapy (TFP), Schema focused treatment (SFT), Mentalization based 
treatment (MBT), and Dialectic behavioural treatment (DBT). All of these treatments has a 
primary focus on BPD, although MBT also have shown promising results in one study of 
patients with BPD and co-occurring antisocial PD (Bateman & Fonagy, 2008b). Cognitive 
treatment has been most studied as short-term treatment, but one RCT studying long-term 
cognitive treatment found no additional effect of this treatment compared to treatment as 
usual (Davidson et al., 2006a). 
Two studies have addressed the effectiveness of Transference Focused Psychotherapy 
(TFP), one which is a comparison with Schema Focused Therapy (SFT) (Giesen-Bloo et al., 
2006), and one comparing TFP with DBT and supportive treatment (Clarkin et al., 2004; 
Clarkin et al., 2007). Both studies show that patients with BPD respond to the dynamic 
structured treatments in an outpatient setting. Changes were found in multiple domains of 
outcome, although the drop-out rate was significantly higher in TFP compared to SFT. SFT 
showed convincingly good results in the Giesen-Bloo study, and although these findings 
must be replicated, SFT seems promising as a structured treatment for BPD patients. The 
studies has been criticised for poor external validity as the treatments in question were 
highly specialised, therapists were trained and supervised by experts throughout the 
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treatment, and the patients were supposed to benefit from outpatient treatment. Thus, the 
treatments might be difficult to implement in the health care clinics.  
Mentalization based treatment (MBT) has been studied in one RCT comparing a partial 
hospitalisation program with standard psychiatric care. They found that the superiority of 
partial hospitalisation was maintained in the 18 months follow-up (Bateman & Fonagy, 
2001). At the 8 year follow-up they concluded that longer-term changes were stimulated 
(Bateman & Fonagy, 2008a).  
DBT’s specific ability to reduce drop-out, self-injury and need for emergency inpatient 
treatment has been proven in a number of RCT’s (Linehan et al., 1991; Linehan et al., 1993; 
Linehan et al., 1994; Linehan et al., 2006; Verheul et al., 2003). Although many studies 
have reviewed the emerging research in the field little is known about predictors of DBT 
treatment outcome, partly because most of the outcome studies have been with relative 
small samples that do not provide statistical power for identifying such predictors (Koerner 
& Linehan, 2000; Lynch et al., 2007; Lynch et al., 2006; Robins & Chapman, 2004). 
The above studies of outpatient psychotherapy for BPD, conducted in accordance with 
specific treatment models and manuals, have all shown significant reductions in dropout 
from therapy, remission of BPD diagnoses and changes on clinical variables compared to 
treatment as usual. It may seem as if the selection and consistent application of a coherent 
and understandable treatment model is likely to be more important than the choice of a 
specific theoretical treatment reference. On the other hand, all of these studies can be 
criticised for low generalizability. The treatments are highly specialised and the patient 
group has mainly comprised BPD patients.  
Following the differences in theoretical orientation, focus, and modes of treatment, there is a 
question of the impact of differences in treatment dosage or length of treatment. The 
American Psychiatric Association’s (APA’s) treatment guidelines recommend  that BPD 
patients are given 1) long-term, individually adapted combined treatment in the form of 
“psychiatric management”, treatment with medication, crisis interventions, and psychosocial 
support, as well as 2) at least one year of psychotherapy (American Psychiatric Association, 
2001). Thus, long-term treatment is recommended, although type or modality of treatment is 
not specified. Taking into account differences in severity of the disorder and type of 
diagnoses, emerging questions might be how long is long-term treatment, and whether 
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short-term treatment may be adequate for some patients. So far, these questions are 
empirically unanswered.  
 In a recent study with a non-PD sample, patients receiving short-term therapies displayed 
heightened work ability more quickly than patients in long-term therapy, but long-term 
therapy seemed more effective than short-term therapies in the long run (Knekt et al., 2008). 
The unpublished Munich study seems to point in the same direction (Huber et al., 
unpublished material). As yet, there has not been published any RCTs on short-term versus 
long-term treatment with PD samples only, but several studies have investigated the effect 
of short-term treatment for PDs. These studies indicate that both short-term cognitive and 
short-term dynamic psychotherapy earn its place among the treatment modalities for 
patients with PDs. The patients in these studies are not as severely disturbed as patients in 
studies of long- term treatment, and one may speculate if short-term treatment might be 
especially effective in treating moderately severe patients with PDs in cluster C (Abbass et 
al., 2008; Emmelkamp et al., 2006; Svartberg et al., 2004).  
A dimension adding complexity to the research of PD treatments is the different treatment 
modalities seen in clinical practice. SFT and TFP are mainly individual approaches, 
although SFT are also developing for use in psychotherapeutic groups. MBT are used both 
in groups and individual treatment, and the DBT program consists of parallel group and 
individual treatment. In addition, patients with PDs receive a variety of inpatient treatments, 
day hospital treatments, day-care treatments, group treatments and different combinations of 
these treatment modalities. It has been suggested that more progress may be found in studies 
that integrate different modes of treatment rather than compare rivalling theoretical 
orientations (Bartak et al., 2007). For the current thesis, a computerised search for studies of 
PD treatments was performed (1974 - 2007), and 37 studies were found where other 
treatment modalities than individual psychotherapy was part of the treatment. An 
impression based on the latter search was that there is still a lack of evidence-based 
knowledge regarding the optimal format and length of treatment, and treatments for the 
mixed spectre of PDs. Verheul and Herbrink (Verheul & Herbrink, 2007) reviewed four 
different formats and settings for psychotherapy delivery, that is, outpatient group 
psychotherapy, outpatient individual psychotherapy, inpatient psychotherapy and day 
hospital psychotherapy. Although they concluded that various psychotherapeutic treatments 
had proven to be effective in reducing symptoms and personality pathology, the two formats 
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of most interest with respect to both effectiveness and cost were outpatient individual 
psychotherapy and various forms of day hospital treatment. 
In Norway, various types of day hospital treatment are probably the most developed 
specialised multimodal treatment for PDs. At present, there are 16 units in the Norwegian 
Network of Psychiatric Day Hospitals Day (the “Network”) specialised in group based PD 
treatment (Geir Pedersen, personal communication). Day hospital treatment, a partial 
hospitalisation in which the patients receive from two to five days of psychotherapy a week 
but live at home, is a more time-intensive treatment than outpatient individual 
psychotherapy, but less time intensive than inpatient treatment. It differs from day care in 
the emphasis given to psychotherapy. Day hospital treatment stands out as a multi-
component eclectic treatment that includes cognitive, behavioural, and psychodynamic 
elements, with a diversity of profiles across hospitals and countries (Kallert et al., 2004a). 
The use of day hospital treatment has increased in Europe during recent decades (Kallert et 
al., 2004a). In Germany, there is a trend towards replacing the traditional inpatient units for 
psychosomatics and psychotherapy with day treatment programmes (Zeech et al., 2005). 
This trend is supported by a few studies reporting day hospital treatment as being more 
efficacious and cost-effective than inpatient treatment (Chiesa et al., 2004; Kallert et al., 
2004b). 
Two randomised controlled studies have reported promising effects of day hospital 
treatment. Piper and colleagues (Piper et al., 1993), who compared the efficacy of day 
hospital treatment, lasting four to five months, to a waiting list control group, found a mean 
difference in effect size of 0.71 in favour of day hospital treatment. Patients in their study 
sample were diagnosed with PDs or major depression, and showed a moderate level of 
psychosocial dysfunction. Bateman and colleagues (Bateman & Fonagy, 1999), who studied 
a sample of more poorly functioning patients with BPD, found that MBT based day hospital 
treatment with a time limit of 18 months was superior to standard psychiatric care, and that 
day hospital treatment also showed considerable cost savings after treatment (Bateman, 
2003; Bateman & Fonagy, 2008a). Results from naturalistic cohort studies have also shown 
effects of day hospital treatment for patients with various types of PDs (Karterud et al., 
1992; Karterud et al., 2003; Krawitz, 1997; Wilberg et al., 1998; Wilberg et al., 1999). The 
scarcity of RCTs for day hospital treatment vs. outpatient care for patients with PDs requires 
further research as pointed out in one Cochrane review (Marshall et al., 2001). They 
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concluded: “there is only limited evidence to justify the provision of day treatment 
programmes and transitional day hospital care, and no evidence to support the provision of 
day care centres” (Marshall et al., 2001, p.2). Moreover, there is a need of knowledge 
concerning the various elements within day hospital treatments. The Ullevål Personality 
Project (UPP) started in 2004 as a response to the lack of basic research on day hospital 
programmes pointed out in the Cochrane review. 
The most frequently studied treatment programs have been followed by long-term outpatient 
psychotherapy, which appears to provide good value (Bateman & Fonagy, 2001). Bateman 
and Fonagy (Bateman & Fonagy, 2001) reported very good outcomes from their outpatient 
phase consisting of group psychotherapy provided twice a week, while Chiesa and 
colleagues (Chiesa et al., 2004), who added individual support to their group therapy in the 
second phase of inpatient treatment, observed good results from this combined treatment 
approach. On the other hand, in the prospective naturalistic studies of Karterud et al. 
(Karterud et al., 2003) and Wilberg et al. (Wilberg et al., 2003), short-term day treatment 
produced good outcomes, whereas only modest gains were obtained from the following 
outpatient group psychotherapy phase. One explanation of the observed difference in results 
might be that patients respond to specific modes or doses of treatments according to the 
severity of their PD diagnoses. More studies are needed to clarify the effects of different 
modalities, dose and intensity of treatment. 
Another limitation in studies of PD treatment is linked to the significantly increased odds of 
axis I disorders in patients with axis II disorders as found in epidemiological studies (Grant 
et al., 2004). Studies investigating effectiveness of treatment have mainly used symptom 
measures for estimating change dimensionally. The most frequently used measures are the 
symptom check list (SCL-90), Beck depression scale, measures of interpersonal problems, 
and different forms of other measures correlating high with current symptom distress. Short-
term effects probably mainly affect the PD criteria that appear less trait like (McGlashan et 
al., 2005). Thus, one might speculate if the measures used in most treatment studies are able 
to detect changes in personality pathology. The use of symptom measures might question 
the interpretation of the results from these studies. Thus, developing instruments that assess 
the core pathology of PDs is an important task for further progress in the field.  
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1.3 Personality dysfunction and assessment of change 
The extended use of symptom measures, and lack of measures of personality pathology in 
PD research and the clinic, has been critically commented throughout the field. One possible 
explanation of the lack of valid and clinical useful assessments of PD pathology might be 
the different theories concerning core PD pathology.  
One example is the definition of BPD as a disorder in the self-structure brought about 
through attachment patterns shaped during development (Fonagy et al., 2002). Thus, the 
disorder is environmentally induced distortions of psychological functioning, which 
decouples key mental processes necessary for interpersonal and social function. An object 
relational model would emphasise the degree of differentiation and integration of self and 
other representations along with affective valence as constituting personality organisation. 
Kernberg distinguishes between three levels of personality organisation: neurotic, borderline 
and psychotic (Kernberg, 1984) where most patients with PDs are on the borderline level of 
organisation. Cognitive theory also has an emphasis on the patient’s interpersonal 
relationships and assumes that the individuals perception and interpretation of situations 
shapes his or her emotional and behavioural responses to a situation (Beck et al., 1979). 
Thus, psychopathology is the result of systematic errors, biases and distortions in perceiving 
and interpreting events, resulting in dysfunctional responses which may have consequences 
that serve to perpetuate the dysfunctional cognitions (Young, 1999). Instruments assessing 
the core pathology in accordance with these theories have been developed, or the 
development is in progress. Such instruments heighten the internal validity of theory 
specific treatment studies, as they will be able to detect change in the areas where the 
specialised treatments focus their interventions. On the other hand, the strong internal 
validity weakens the external validity as such theory specific instruments are not appropriate 
for comparison between studies with different treatments. Thus, the generalizability of the 
results would be low. Moreover, regarding clinical utility, most theory specific assessments 
are based on interviews and therefore time consuming (e.g. the Adult Attachment 
Interview). In addition, they may require prolonged training for management and scoring. 
So, there is a challenge to assess PD core pathology cutting across theories and diagnoses 
and being useful for research as well as in the clinic. 
There is a growing acceptance that there is a dimensional continuity between normal 
personality and personality pathology (Livesley & Jang, 2000; Trull, 2005; Verheul, 2005; 
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Widiger & Simonsen, 2005). Several researchers hold the view that normal personality 
comprises constitutionally based temperament, or basic tendencies (McCrae et al., 2000; 
Skodol et al., 2002b), as well as adaptive capacities developing in interaction with early 
caregivers and social environment(Livesley & Jang, 2005). In line with this view, the basic 
tendencies that form personality style are distinguished from the subject’s personality 
function referring to the functioning or malfunctioning of the adaptive capacities. PDs then 
involve a harmful dysfunction in the normal adaptive functions of the dynamic personality 
system, and not just statistical deviance on personality trait dimensions. Empirical studies 
underline this notion as scores on dimensions of normal personality functioning do not 
appear to be as strongly associated with functional impairment as the psychopathology of 
DSM personality disorder (Skodol et al., 2005a). It has been suggested that dimensional 
normal personality traits provide an alternative way to classify personality disorder (Widiger 
& Costa, Jr., 1994; Widiger & Lowe, 2007). Most of these studies has relied on the five 
factor model (FFM), which defines a structure characterised by the five higher order traits: 
extraversion, neuroticism, agreeableness, conscientiousness and openness to experience 
(McCrae et al., 2000; McCrae et al., 2001). But although studies have demonstrated that the 
FFM account for a substantial proportion of the variance in PD diagnoses (Nestadt et al., 
2008) there are limitations regarding the extent of  FFM capturing the complexity of PDs, 
strength of the correlations between PD diagnoses and FFM traits, and questions are being 
raised whether the FFM  is actually helpful in understanding PDs and in making clinical 
decisions. Other instruments aiming at a dimensional assessment of personality dysfunction 
are: the SASB (Benjamin et al., 2006), TCI (Svrakic et al., 2002), DAPP-BQ (Livesley et 
al., 1998), SWAP-200(Mullins-Sweatt & Widiger, 2008; Westen & Shedler, 2007), and the 
SIPP-118 (Verheul et al., 2008), which is the focus of one of the papers in this thesis. Most 
of the instruments suffer from limitations such as being theory specific, too time consuming 
because of length of the instrument or because of interview as method, or that the 
instrument has not been validated in external studies. 
At present, there is a lack of valid instruments that measure the common core features of 
maladaptive personality pathology. Such a measure of “core pathology” should preferably 
be based on clinical theories of personality development and should focus on common 
dysfunctions across the existing diagnostic categories. The Severity Indices of Personality 
Problems (SIPP-118) is a newly developed instrument addressing most of the challenges 
assessing PD core pathology (Verheul et al., 2008). SIPP-118 is developed in consistency 
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with the view that the changeability of personality and PDs is likely to be more pronounced 
for (mal)adaptive capacities than for the more stable constitutionally based characteristics 
(McGlashan et al., 2005). Adaptive capacities usually refer to the dynamic organisation of 
personality that concerns the regulation of self and relationships with others, and comprise 
characteristics like affect- and impulse regulation, self- and other representations, identity, 
coping strategies, and acquired skills. Thus, a dimensional measure of core personality 
pathology might be applicable both to clinical work with patients as well as in research on 
treatment change. As emphasised by Livesley (Livesley & Jang, 2005), adaptive capacities 
are essential for a subject’s ability to fulfil major life tasks. Even if some of the adaptive 
capacities of personality to some degree may be influenced by biological constitution 
(McCrae et al., 2000), the conceptual distinction between basic tendencies and adaptive 
capacities may have heuristic value for the development of a further understanding of the 
core pathology of PDs. This might be especially important in the understanding of 
maturation and change in PDs during adult life, and change due to therapeutic interventions. 
The SIPP-118 was developed by a research group in the Netherlands in cooperation with an 
English research group (Andrea et al., 2007). A conceptual model was first developed 
through consensus meetings of ten clinical experts in the field of personality and PDs. They 
all agreed with the notion that the concept of changeable core components is more or less 
synonymous to that of adaptive capacities, with PDs characterised by deficient levels of 
adaptive capacities. The experts were requested to identify as many specific adaptive 
capacities as possible and 264 items were originally elaborated. The items were then refined 
through extensive qualitative evaluation, and quantitative pilot studies (Andrea et al., 2007; 
Verheul et al., 2008). So far the SIPP-118 has not been tested in PD samples other than 
those used for the original development of the instrument. 
1.4 Cost-effectiveness of treatment 
Effectiveness of treatment might not yield all relevant information concerning the treatment 
in question. Health authorities want to be informed of the cost of treatment. In addition, the 
knowledge of health service utilization may be clinically relevant in the work with PD 
patients struggling with interpersonal problems when facing the health services.  Various 
methods to assess costs and benefits exist: 
Cost of illness (COI) measures the impact of the economic burden of disease. This is the 
most comprehensive method for assessing costs, as it estimates the total costs for society 
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arising as a consequence of the patients’ lifestyle, costs of treatment and use of health care 
services, productivity losses due to morbidity, and productivity costs due to mortality. Such 
studies can be used to identify avoidable costs or pinpoint the need for development of 
health promotion, prevention programmes or treatment programmes. In performing a COI, 
there is a choice between a bottom-up and a top-down approach. The bottom-up approach 
gathers data from a small sample and extrapolates it to the total population. The top-down 
approach starts at total cost per healthcare sector and breaks it down to costs of a specific 
disease. To our knowledge, only one such study has been published in the PD field (van 
Asselt et al., 2007). 
Cost-benefit analysis is a complete evaluation involving all sectors of society. It is 
ambitious, difficult and rare within health or other public sectors. The resulting information 
allows resources between different sectors to be evaluated, for example between health and 
education or between addiction treatment and building a new highway. 
Cost-utility analysis attempts to determine deployment of resources within a programme. 
The costs of alternatives are measured and the consequences are estimated in indexes of 
health gain. The mostly used index is Quality of life years (QALY) which is based on the 
estimation of the number of years of life that would be added by a medical intervention. 
Each year in perfect health is assigned the value of 1.0 down to a value of 0.0 for death. If 
the extra years would not be lived in full health, for example if the patient would lose a 
limb, or be blind or be confined to a wheelchair, then the extra life-years are given a value 
between 0 and 1 to account for this. 
Cost-effectiveness analysis compares the effectiveness of different treatment offers by 
taking into account the cost of the implementation of the treatment and the effectiveness of 
the intervention. 
There has been an increased interest in the field of cost analyses the last years. However, 
cost studies require careful consideration regarding methodological issues and relevant 
studies are still scarce. There are one formal COIs (van Asselt et al., 2007), a few cost-
utility studies, and various studies which have assessed the health care utilization and cost of 
alternative treatments. There is still a need for more knowledge in this field.  
PDs are associated with poor health-related lifestyle choices, more exposure to violence, a 
higher risk of suffering from chronic physical conditions, and symptom disorders like 
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anxiety, mood disorders, suicidality, eating disorders, drug, and alcohol abuse. PDs are also 
associated with the use of more medication, and patients may show poorer response to both 
somatic and psychiatric treatment (Frankenburg & Zanarini, 2004; Smith & Benjamin, 
2002). In addition, PD patients have more extensive histories of psychiatric outpatient, 
inpatient, and psychopharmacological treatment than e.g. patients with major depressive 
disorder and no PDs (Bender et al., 2001; Bender et al., 2006). The impairment following 
PDs have been well documented (Skodol et al., 2002a; Skodol et al., 2005c; Stolk et al., 
2002), and the “burden of disease” in patients with PDs have been compared with the 
burden in severe somatic illnesses, such as Parkinson’s disease or rheumatic disease 
(Soeteman et al., 2005). From the perspective of society, the social costs associated with 
PDs are significant. Rendu (Rendu et al., 2002) found that non-healthcare costs were higher 
for patients with PDs compared to non-PD patients, although PDs were not independently 
associated with higher costs as the interaction between PDs and common mental disorders 
were the significant predictor. The above studies showing both healthcare costs and non-
healthcare costs for personality PDs in general and BPD in special, indicates substantial 
societal costs for this group of patients. This was confirmed in a prevalence-based study of 
BPD patients from the Netherlands estimating the total societal cost, including all healthcare 
costs, medication, informal care, productivity losses, and out-of pocket expenses(van Asselt 
et al., 2007). They found that cost per BPD patient were €16,852 resulting in a yearly cost of 
illness of €2,222,763,789 where 22% were healthcare related.  
As described, there is now evidence that psychotherapy in general is an effective treatment 
for BPD showing good results in reducing drop-out from therapy, remission of PD 
diagnoses, and change on clinical variables (Bateman & Fonagy, 2001; Clarkin et al., 2007; 
Giesen-Bloo et al., 2006; Svartberg et al., 2004). Most of the treatments are resource 
intensive long-term treatments, but taking into account the substantial societal costs for 
these patients one can argue that treatment will pay off. One Australian study found that 
based on the decrease in hospital treatment alone, psychotherapy for BPD patients resulted 
in a total saving of $8,431 Australian dollars per patient for one year of treatment 
(Stevenson, 1999).  
Chiesa and colleagues (Chiesa et al., 2002) compared three different health services; one 12 
month inpatient hospital program, one “step-down” program consisting of 6 months of 
inpatient treatment followed by 12 months of outpatient therapy, and one program with 
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routinely available community services. Significant savings were achieved in the two 
specialist programs compared to the community services, with the step-down program as the 
most cost-effective (Beecham et al., 2006; Chiesa et al., 2002). In another study, health care 
utilization of BPD patients in partial hospital treatment were compared to treatment as usual 
(TAU) 6 months before treatment, during 18 months of treatment, and over an 18-month 
follow-up period (Bateman, 2003). The results showed that there were no cost differences 
between the groups during treatment. The costs of partial hospital treatment were offset by 
reduced emergency room treatment and less psychiatric inpatient care. Accordingly, during 
follow-up the partial hospitalisation group showed a decrease in costs which was not 
apparent in the TAU group (Bateman, 2003). A summary of DBT suggests it might have 
potential to be cost-effective, although so far the analyses do not support the cost-
effectiveness of DBT (Brazier et al., 2006). Palmer and colleagues concluded that although 
total costs per patient in Cognitive Behaviour Therapy (CBT) were lower than for patients 
receiving usual care alone, they could not demonstrate any advantage in cost-effectiveness 
because the CBT group also reported a lower quality of life. In sum, cost-effectiveness 
studies on PD treatments are still sparse and inconclusive. Limitations regarding the low 
number of patients in these studies and problems estimating indirect costs make the results 
only suggestive. Thus, further studies are needed.  
1.5 Summary 
As a summary we can conclude that there is a high prevalence of PDs in the general 
population, and a very high prevalence in clinical populations. PDs affect functional 
impairment to a high degree, and the personal burden of the disease and societal costs 
associated with the disorders are considerable. Thus, offering effective and cost reducing 
treatment is in the interest for the individuals, their families and the state. Although there are 
well-designed studies leading to treatment optimism, the treatment trials still tend to focus 
on patients with BPD in outpatient psychotherapy. Evidence based knowledge regarding 
optimal format and length of treatment for the various range of PDs seen in clinical practice 
is still lacking. The two formats of most interest with respect to both effectiveness and cost 
might be outpatient individual psychotherapy and various forms of day hospital treatment. 
Most former treatment studies suffer from the lack of assessing PD pathology. There is a 
need for the development of instruments measuring dimensional aspects of core PD 
pathology. SIPP-118 is such an instrument, but has yet to be validated outside the 
developmental studies.  
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2. Aims of the study 
The Ullevål Personality Project (UPP) aimed at comparing two treatment modalities (CP vs. 
OIP) for patients with PDs. The CP treatment comprised initial day hospital treatment 
followed by combined psychotherapy, and the OIP treatment was outpatient individual 
treatment by private practitioners. The requirement of using not only symptomatic measures 
but assessing dimensional measures of PD core pathology led to the first main aim of the 
thesis: 
1. Evaluating the validity of the SIPP-118. 
Comparing the two treatments implied randomisation of the patients and estimating the 
efficacy through various clinical measures and health utilization costs. The second main aim 
of the thesis was:  
2. Comparing CP and OIP both regarding clinical effect and costs.  
2.1 Paper I: Validation of the SIPP-118 
So far the SIPP-118 has not been tested in PD samples other than those used for the original 
development of the instrument (Verheul et al., 2008). To explore the generalizability of the 
results from the original Dutch sample, the internal and external validity of the measure 
needed to be examined. The SIPP-118 was translated to Norwegian and our sample of 
poorly functioning patients with PDs was compared with two Dutch samples. The aims 
were to replicate the Dutch study, investigate the SIPP-118 as a valid measure of general 
personality pathology, and to explore the SIPP-118 as a severity measure for PDs. More 
specifically, the aims of the present study were: 
1. We expected the facets of the SIPP-118 to be internally consistent, and inter-
correlations between facets and between domains to be low to moderate. 
2. We expected the Norwegian patient sample to be equal to the Dutch PD sample and 
differ significantly from the Dutch normal sample on SIPP-118 scale scores.  
3. We expected a moderate relationship between SIPP-118 and well established clinical 
measures of psychosocial function and symptomatic distress.  
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2.2 Paper II: Short-term change 
In this first efficacy study of CP and OIP the aim was to examine the short-term effects of 
the intensive initial treatment in CP with short-term effects in OIP at 8 months follow-up 
evaluation. We compared the initial 18 weeks day hospital treatment (DHP) to OIP. There 
are several differences in the treatments being tested. Compared to OIP, the DHP is 1) more 
intensive, 2) involves more therapeutic elements (e.g. psychodynamic, cognitive, and 
behavioural therapeutic techniques), and 3) involves a systematic collaboration between 
several therapists. We expected improvements in both treatments, but due to the differences 
in the two treatment modalities we expected some increased benefit of the DHP treatment. 
1. We expected a lower attrition rate in DHP than in OIP. 
2. We expected that fewer patients in DHP would report self-injury and suicide 
attempts compared to OIP at 8 months follow-up. 
3. We expected moderate improvements on clinical measures in both treatments, but 
with a significant difference in favour of DHP. 
4. We expected that patients with more severe personality pathology would benefit 
more from DHP than from OIP. 
2.3 Paper III: Long-term change 
At 18 months follow-up we expected positive long-term effects in CP in line with other 
studies finding small short-term effects but more extensive long-term effects (Bateman & 
Fonagy, 2008a; Blum et al., 2008).Thus, our general assumption was that the patients would 
benefit more from the intensive combined treatment following day hospital treatment (CP), 
than from the OIP. More specifically, the aims of the 18 months follow-up study were: 
1. We expected improvement on the wide range of clinical measures with a significant 
difference in favour of CP.  
2. We expected a lower termination rate in CP than in OIP.  
3. We also examined if there were specific PD criteria interacting with outcome in the 
two treatments. 
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2.4 Paper IV: Health utilization costs 
The aim of the study was to compare health utilization costs in CP to health utilization costs 
in OIP at 8 months follow-up and 18 months follow-up. There is no doubt that the extensive 
CP treatment is more costly than OIP in direct treatment costs, especially in the initial phase 
where the patients in CP received intensive day hospital treatment. Yet, comparable studies 
have shown that higher treatment costs may be compensated by reduced use of additional 
health care services already during treatment (Bateman, 2003). Hence, the aims were:  
1. We expected a reduction in additional health care costs in CP compared to OIP at 8 
months follow up, and we expected this reduction to remain at the 18 months follow-
up.  
2. Thus, we expected the total costs for the CP patients to be similar to OIP at 8 months 
follow-up. 
3. We expected that at 18 months follow-up the total costs in CP would be lower 
compared to OIP. 
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3. Methods 
3.1 Ullevål Personality Project – design 
Figure 1: Study design Ullevål Personality Project 
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The Ullevål Personality Project (UPP) started in 2004 as an answer to the lack of basic 
research on day hospital programmes pointed out in the Cochrane review (Marshall et al., 
2001). The project is carried out at Ullevål University Hospital, Oslo, Norway by 
Department for Personality Psychiatry in cooperation with Department for Research and 
Education and the University of Oslo. The study is a randomised controlled trial (RCT) 
comparing two modalities of treatment for patients with various PD diagnoses. 
Consecutively evaluated patients who agreed to participate in the study were randomly 
allocated to one of the following treatment conditions: a) Combined Psychotherapy (CP) 
which consisted of initial day hospital treatment followed by long-term combined group and 
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individual psychotherapy, or b) Outpatient individual psychotherapy (OIP). All patients 
were evaluated on a wide range of clinical measures at baseline, 8 months, 18 months, 36 
months (in progress) and 72 months (starting 2010). All patients were diagnosed on axis I 
and axis II at baseline, and will be re-diagnosed at the 36 and 72 months evaluations. In 
addition, an extensive battery of clinical measures and interviews were used. The study 
design is described in Figure 1. 
3.2 Therapy 
Combined psychotherapy (CP) 
Combined Psychotherapy (CP) is a long-term treatment defined in UPP as the combination 
of day hospital treatment (DHP) followed by conjoint individual and group psychotherapy.  
Day hospital psychotherapy (DHP) 
The patients allocated to CP were initially offered 18 weeks day hospital treatment (DHP). 
The DHP treatment consisted of a combination of psychodynamic and cognitive-
behavioural group therapies 3-4 days a week, and was adhering to relational 
psychodynamics with reference to group analysis, self-psychology and mentalization based 
treatment. The staff received biweekly video based supervision by a senior therapist. 
Although written guidelines outlining the therapeutic stance was elaborated, there was no 
formal manual which could serve as a standard for measuring treatment adherence. The day 
treatment program had capacity for 18 patients, and all groups had a maximum of nine 
patients and two therapists. Due to difficult research logistics following the RCT 
procedures, the actual number of patients was lower for some periods. The treatment 
program is considered rather typical for the day hospital treatment tradition in Norway 
(Karterud et al., 2003).  
The psychodynamic group therapy was considered to be the core of the treatment program 
and conducted according to modified group analytic principles. It was provided 1,5 hour 
twice a week, with an emphasis on maladaptive interpersonal transactions, affect 
dysregulation, attachment issues, self object needs and self object failures. 
The art group therapy was also provided 1,5 hour twice a week and were conducted 
according to guidelines described by Johns & Karterud (Johns & Karterud, 2004). 
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The cognitive group therapy was provided one hour once a week. The group worked with 
early maladaptive schemas which had been identified by the self report instrument Young-
75 (Young, 1999). 
The problem solving group therapy focused upon strategies for solving social, economic and 
interpersonal problems and lasted for one hour once a week.  
The cognitive-behavioural group therapy (CBGT) for patients who suffered from additional 
anxiety disorders was optional. It lasted for 1,5 hours once a week and was conducted 
according to generally accepted CBGT guidelines which included individualised exposure 
home lessons (Clark, 1999; Hoffart et al., 1993; Marks, 1987).  
The median group therapy (“community meetings”) assembled all patients and several staff 
members for one hour twice a week. It addressed general issues relevant to treatment 
alliance, i.e. treatment ideology, group norms, adherence to the program, cooperation and 
the dynamics of the unit as a whole. 
Pharmacotherapy: A majority of the patients (70%) were on medication by referral and the 
medication was evaluated and eventually modified by the staff psychiatrist who also 
monitored the pharmacotherapy during the treatment. The APA BPD guidelines (American 
Psychiatric Association, 2001) were followed with a somewhat overall restrictive attitude. 
The staff dynamic group met one hour biweekly with an external consultant. Working with 
patients with PDs is well known to provoke counter transference reactions and 
disagreements among staff (Rossberg et al., 2007). The primary task of this group was to 
restore the vitality of the staff and cultivate a sound collective reflective culture. 
Staff meetings were held three times a week, orchestrating ongoing events, mutual 
information and ad hoc supervision.  
Follow-up conjoint treatment 
After ending the short-term day hospital treatment all patients were offered continuous 
outpatient treatment. The mean length of the transition phase between day hospital treatment 
and the following therapy was 19 days (SD = 19). The follow-up treatment offered was once 
a week outpatient individual psychotherapy (with a predefined maximum length of 2.5 
years) conjoint with 1½ hour group psychotherapy once a week (with a predefined 
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maximum length of 4 years). Conjoint therapy is defined by not having the same therapist in 
individual and group sessions. Research on long-term efficacy of this treatment modality is 
scarce (Karterud et al., 2007). The individual therapy adhered to psychodynamic principles 
while the group therapy adhered to modified group analytic principles. The group therapists 
and the individual therapists met approximately twice a year to address process and progress 
issues.  
Out patient individual psychotherapy (OIP) 
The patients allocated to OIP received eclectic individual therapy defined as therapy 
according to their usual practice and in agreement between patient and therapist, mainly 
conducted in private practice. The researchers gave no instructions to the OIP therapists 
regarding the duration and intensity of psychotherapy, nor did they interfere with any 
treatment decisions in the OIP condition. Thus, length of treatment was according to 
consecutive evaluation of the treatment, and the agreement between therapist and patient. 
The duration and treatment attrition will be discussed later in the thesis. The frequency of 
therapy ranged from once a month to three times a week, with 83% of the patients attending 
therapy once a week. This is comparable with the average treatment frequency in outpatient 
psychotherapy provided by private practitioners in Norway, which has been reported as one 
consultation a week with a mean treatment duration of 1.5 to 2.0 years (Gråwe et al., 2005; 
Husum et al., 2005).  
3.3 Therapists 
Individual therapists 
To recruit individual therapists, a mail was conducted to all private practitioners in Oslo 
who had a contract with the State Health Insurance Fund, as well as professionals working 
at mental health centres. After a short description of the project, the specialists were asked if 
they were willing to partake, either as experimental (CP) therapists or as control (OIP) 
therapists. The therapists who responded were assigned to the experimental or control 
therapy group according to their own preferences. The treatment expenses for both 
treatments were covered by the State Health Insurance Fund. At the beginning of the study, 
the therapists completed a self-report questionnaire covering theoretical preference, 
education, work experience, and work satisfaction. When the patient(s) terminated 
treatment, a second questionnaire was administered to obtain reports of frequency of 
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treatment, duration of treatment, and the reason for ending therapy. There will be a 
discussion of these issues later in the thesis. 
OIP individual therapists 
Thirty-two external therapists were recruited as control therapists (16 psychologists, 15 
psychiatrists and one resident) who provided psychotherapy consistent with their usual 
practice style. Each therapist was allocated between one and three patients, and signed a 
formal treatment contract with the project. The OIP therapists comprised 12 females and 20 
males with a mean age of 55 years (SD = 7.6). Their mean work experience as 
psychotherapists was 20 years (SD = 8.0). Most therapists reported adherence to 
psychoanalytic/psychodynamic theories, although cognitive and systemic elements were 
present. The therapists were generally satisfied with their work as a psychotherapist, as 
indicated by a mean of 4 (SD = 0.6) on a six-point satisfaction scale ranging from 0, no 
satisfaction, to 5, very satisfied. The therapists were invited to attend an annual one-day 
motivational seminar on general aspects of PDs. 
CP individual therapists 
The individual therapists involved in the follow-up outpatient CP treatment comprised 16 
psychologists, 12 psychiatrists, 2 psychiatric nurses and one social worker (24 external 
therapists and seven therapists from the Department of Personality Psychiatry). The mean 
age of the individual therapists was 50 years (SD = 8), and 58% were female. Each therapist 
received one to three patients for treatment. The therapists were generally very satisfied 
with their work as psychotherapists, indicated by a mean of 4.2 (SD = 0.5) on a six-point 
satisfaction scale ranging from 0, no satisfaction, to 5, very satisfied. Their mean work 
experience as psychotherapists was 16 years (SD = 8.0). Although there was written 
guidelines outlining the therapeutic stance adhering to self-psychology and mentalization, 
no formal adherence was tested, and most therapists probably delivered therapy according to 
their usual practice. The therapists were invited to one-day seminars twice a year on 
conjoint therapy, and they were invited to receive monthly supervision in groups, focusing 
on conjoint treatment.  
Group therapists 
The group therapists both in the day hospital treatment and the following conjoint therapy 
were regular staff from the Department of Personality Psychiatry, Ullevål University 
Hospital. In the day hospital treatment there were 5.5 full-time positions divided among ten 
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group therapists. There were three psychiatric nurses, two psychiatrists, a residential doctor, 
an art therapist, a physiotherapist, a social worker and a psychologist. Seven of the ten 
therapists were trained group analysts (five-year training). The therapists’ mean age was 48 
years (SD = 9), and 80% were female. These therapists also conducted the follow-up 
outpatient group therapies. 
3.4 Assessments 
Axis I diagnoses 
Symptom disorder diagnoses were based on the Mini International Neuropsychiatric 
Interview (M.I.N.I) for axis I diagnoses (Sheehan et al., 1994), and decided according to 
DSM-IV (American Psychiatric Association, 1994). Twenty-five videotaped interviews 
were rated by an independent rater. The kappa values for seven axis I diagnoses, represented 
by at least five cases, were .51 for major depression, .60 for dysthymic disorder, .92 for 
social phobia, .52 for obsessive-compulsive disorder, .51 for panic with agoraphobia, .41 for 
general anxiety disorder and .52 for alcohol misuse disorders. Altogether, the 25 patients 
received 88 axis I diagnoses, and there was agreement with respect to 57% of these 
diagnoses. When pooling the diagnoses, the kappa values were .58 for the patients having 
any anxiety disorder and .71 for any substance misuse disorder. There was agreement for 23 
of the 25 patients who had any type of mood disorder, but the kappa value could not be 
computed due to empty cells in the cross-tabulation. 
Axis II diagnoses 
PD diagnoses were decided according to DSM-IV criteria using the SCID-II interview 
(First, 1994). Twenty-four videotaped SCID-II interviews were rated by an independent 
rater. The kappa values for three PDs, represented by at least five cases, were .75 for 
avoidant PD, .66 for borderline PD, and .71 for paranoid PD, indicating acceptable 
diagnostic reliability. Altogether, the 24 patients received 37 diagnoses of specific PDs. 
There was agreement with respect to 68% of the diagnoses. The number of fulfilled SCID-II 
criteria were used as a dimensional severity measure (Skodol et al., 2005b). The intraclass 
correlation coefficient (ICC 3.2) on number of fulfilled SCID-II criteria was .95 (95% CI: 
0.73 – 1.00). 
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Clinical measures 
Self-injury, suicidal thoughts and suicide attempts 
Self-injury and suicide attempts were assessed by the patients self-report, and then quality 
checked using research interviews and revised if necessary. The criteria for self-injury were 
an intended episode of cutting, burning, etc. without suicidal intent, whereas a suicide 
attempt was defined as an episode with the intention to commit suicide, but the patient 
failed to do so. Suicidal thoughts during the previous seven days were reported as being 
present, or not, and their severity was measured on a 5 point scale with a range from 
“…passing thoughts” to “...did active preparations for suicide”. 
Symptom distress 
The symptom checklist, SCL-90-R (Derogatis, 1983), was used to measure symptom 
distress. SCL-90-R, a self-report questionnaire requiring responses on a 0–4 Likert scale, 
was designed to cover the major symptoms of psychiatric distress, represented by nine 
dimensions that can be meaningfully expressed by a Global Severity Index (GSI). A higher 
score indicates more symptomatic distress. The Beck Depression Inventory (BDI) (Beck et 
al., 1961; Groth-Marnat, 1990) was used to measure characteristic attitudes and symptoms 
of depression. The BDI is a 21-question self-report inventory, with a 0–3 rating scale. A 
sum score (0–63) is obtained by adding up the scores for each of the questions. Sum scores 
between 19 and 29 are regarded as indicating moderate to severe depression, while scores of 
30 and above indicate severe depression. The Beck Hopelessness scale (BHS) (Beck & 
Steer, 1988) is a self-report instrument containing 20 true–false statements designed to 
assess the extent of positive and negative beliefs about the future during the past week. Each 
of the 20 statements is scored as either 0 or 1. A total score is expressed counting the 
pessimistic responses for each of the 20 items. The total score ranges from 0 to 20, higher 
scores indicating a greater level of hope. For the assessment of self-esteem, we applied the 
Index of Self-Esteem (ISE) which assesses the self evaluative aspects of self-esteem 
(Hudson, 1982; Walmyr Publishing CO, 1992). ISE is a 25-item questionnaire measuring 
the degree or severity of a subject’s self-esteem problems. The scale produces scores 
ranging from 0 to 100, with scores above 30 indicating clinical significant problems in this 
area. A 10-point scale assessed subjective Quality of life, a score of 1 representing the least 
perceived quality of life and a score of 10 indicating the highest perceived quality of life. 
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Interpersonal problems 
Self-reported interpersonal problems were assessed by the Circumplex of Interpersonal 
Problems (CIP) (Pedersen, 2000). The CIP is a 0–4 Likert scale, 47-item version of the 
Inventory of Interpersonal Problems (IIP) (Horowitz et al., 1988). A total mean score (CIP) 
was generated to summarise all scores on the subscales. A higher score indicated more 
severe interpersonal problems. The total CIP score correlates .99 with the sum score 
obtained from Alden’s IIP-C (Alden et al., 1990; Pedersen, 2000).  
Personality problems 
A preliminary exploratory version of the Severity Indices of Personality Problems (SIPP) 
consisting of 203 items was translated from English to Norwegian by our research group, 
and then back translated into English by a bilingual translator. The final Norwegian 
translation was determined by group consensus after comparison with the English back 
translated version. In the present studies, we used 118 items similar to the final SIPP-118 
version, with a 0–4 point response scale being used (Verheul et al., 2008). The original 
study showed that the measure comprised 16 facets that were fairly internally consistent and 
uni-dimensional. These facets are clustered into five higher order domains named Social 
concordance, Self-control, Identity integration, Responsibility and Relational functioning, 
which are weighted sums using primary and secondary loadings in accordance with factor 
analyses and qualitative considerations (Andrea et al., 2007). This means that the 16 facets 
contribute to different higher domains with different weights. A description of the higher 
order domains and the facets with the highest loadings on each domain are shown in paper I. 
The SIPP-118 domains were employed as measures of (mal)adaptive personality 
functioning. High scores on these domains indicate higher adaptive functioning, whereas 
low scores indicate more deficient levels of adaptive capacity. The validity of this measure 
of core PD pathology is part of this thesis, and will be thoroughly discussed. 
Psychosocial functioning 
Global Assessment of Functioning (GAF) was applied to assess psychosocial functioning. 
GAF is rated on a scale from 0 to 100, a higher score indicates a higher level of functioning. 
GAF was rated according to a split version, that is, symptoms (GAF-S) and function (GAF-
F) were assessed separately (Goldman et al., 1992). According to DSM-IV, the GAF score 
should be determined with respect to the lowest level of functioning. Thus, only the lower of 
the two scores was used in the analyses. At baseline, GAF was rated by the staff member 
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responsible for the patient’s evaluation after obtaining anamnestic information, completing 
diagnostic interviews (i.e., SCID-II and MINI), and complemented by a 15-minute GAF 
interview developed for the present project (http://personlighetsprosjekt.com/gaf/). A 
consensus was then attained at the staff meeting. At 8 and 18 months follow-up, the GAF 
score was rated by the evaluator accompanied by a consensus method consulting a senior 
GAF expert. For reliability purposes, all GAF interviews at follow-up were recorded and 
scored by two independent evaluators gaining consensus. The reliability for GAF measured 
by Intra Class Correlation (ICC, 3.2) was .94 at 8 months, and .93 at 18 months evaluation.  
GAF-F can be compared to Social and Occupational functioning assessment scale (SOFAS) 
(American Psychiatric Association, 1994) (s.760). GAF-F score 60 was used as a clinical 
relevant cut off score. The GAF scoring manual states that GAF scores above 60 indicates: 
”...some difficulty in social, occupational of school functioning, but generally functioning 
pretty well...”, while GAF scores under 60 is defined by a “...moderate difficulty in social, 
occupational, or school functioning...”.  To reassure clinical significance of the GAF-F 
scores, reliable change based on Jacobson and Truax’ criteria was added as cut-off criteria 
(Jacobson & Truax, 1991). Based on the reliability of the instrument (Pedersen et al., 
2007a), and the standard deviation in our data, a change in GAF-F score of 5 or more was 
estimated as reliable change. Reliability for GAF-F with cut-off score 60 was Phi = .87, 
which indicates a high degree of consensus between the interviewers and the independent 
scorers in distinguishing between GAF-F level below 60 and GAF-F level above 60. 
Costs 
Cost related data were collected from each patient using a health service interview adapted 
for this population and research context. The interview assessed services that were likely to 
bear the major costs (see Table 2 for unit costs). Data were collected for a retrospective 
period of 12 months at baseline, the last 8 months at 8 months follow-up, and the last 10 
months at 18 months follow-up. For both groups, this gave a continuous picture of the use 
of health services throughout the study period. Mean cost per day at day hospital treatment 
was calculated from data on number of full time equivalent therapists and administrative 
staff, registration of personnel allocation of time, and annual accounts from the Department 
of Personality Psychiatry at Ullevål University hospital. Cost per private outpatient 
consultation was estimated from information on annual activity and income from 
participating therapists. Other units costs were obtained from published reports (Halsteinli et 
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al., 2003; NLWA, 2008; Pedersen, 2007b; Petersen, 2007) except community day centre, 
psychiatric nurse and social service visit which were estimated specifically for this project 
on the basis of information from one large municipality. Medication costs were calculated 
by means of standardised price information from the Norwegian Medicines Agency. All unit 
costs are from 2006 when the project started. All costs are presented in Euro, the exchange 
rate used were 1 Euro = 8 NOK. 
 
Table 2: Unit costs 
 Unit costs 
(euro) 
Treatment costs  
Day hospital - per day 165 
Outpatient public - per consultation individual 118 
Outpatient public - per consultation group 59 
Outpatient private - per consultation individual 110 
Outpatient private - per consultation group 45 
Additional health care costs  
General practitioner - per visit 33 
Psychiatric emergency - per visit 163 
Other emergency services - per visit 39 
Psychiatric hospital - per inpatient 24h stay 1 891 
Community mental health centre - per inpatient 24h stay 1 619 
Community day centre per visit 43 
Psychiatric nurse - per home visit 73 
Social service - per visit 28 
1)  Day visit 1/2 of 24h stay 
 
3.5 Procedures 
Evaluation 
Initial diagnostic evaluation and assessments were performed by the regular staff at the 
Department of Personality Psychiatry, Ullevål University Hospital. Initial evaluation lasted 
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between 3-5 sessions for each patient. Final decisions regarding diagnoses and inclusion in 
the project was done at a clinical meeting between the evaluator and one of two senior 
psychiatrists at the department. The 8 months evaluation was carried out by Espen Arnevik, 
and the 18 months evaluation was carried out by a research assistant studying for a master in 
psychology. 
Randomization 
The assurance of the randomization schedule generated by SPSS was maintained by a 
randomization coordinator who was not involved in the patient evaluations. After the initial 
evaluation of the patients and their agreement to participate in the study, the evaluator 
contacted the randomization coordinator to receive a randomization number and information 
regarding treatment allocation. If the patient was randomized to OIP, the evaluator 
contacted an individual therapist so that outpatient psychotherapy could be initiated. The 
patients allocated to CP were placed on a waiting list for day hospital treatment. Three 
patients expressed dissatisfaction with the allocation procedure and withdrew after 
randomization, one from the CP condition and two from the OIP condition. Thus, the total 
number of patients included in the baseline sample was 114. Sixty patients were randomly 
allocated to the CP group, and 54 to the OIP group.  
Ethics 
The patients in the CP treatment were presumed to receive an extensive and good treatment 
offer. Despite the differences in treatment dosage, the patients in OIP also received an offer 
of comprehensive treatment. On average, the patients received treatment that was more 
comprehensive than “treatment as usual”, especially by Norwegian standards. In Oslo, 
poorly functioning patients with PDs may have difficulty gaining access to regular 
psychotherapy within private specialist practices. All participation was based on written 
informed consent. The project is approved by The Data Inspectorate and Regional Ethics 
Committee. No procedures in the project were considered potentially harmful. Publication 
of the study results was not in any way contingent on the sponsor’s approval or censorship 
of the manuscript.  
Medication 
Psychopharmacological consultations with a psychiatrist were part of the initial evaluations 
for all attending patients. In the DHP, medication was monitored during the treatment, and 
modified by the staff psychiatrist when necessary. The APA BPD guidelines (American 
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Psychiatric Association, 2001) were followed with a somewhat overall restrictive attitude. 
In the following CP outpatient treatment collaboration was established with general 
practitioners regarding medication, medical certificates, occupational rehabilitation, etc. The 
OIP therapists were instructed to cooperate with general practitioners and other health 
services according to their usual practice. At follow-up evaluations all patients were offered 
a consultation with a psychiatrist at the Department of Personality Psychiatry. 
Statistics 
All statistics were calculated using SPSS 15.0, SPSS 16.0 or STATA /IC 10.0 for Windows.  
Pearson’s correlation coefficient was applied to test associations between continuous 
variables, and Spearman’s rank-order correlation coefficient was used to test associations 
between dichotomous variables and continuous variables that were not normally distributed. 
Chronbach’s alpha was used to measure inter item consistency of the SIPP-118 facets.  
Five measures were used to test the external validity of the SIPP-118; GAF, CIP, SCL-90-R, 
total SCID-II criteria, and BDI. Because the number of measures increased the risk of type I 
error, a Bonferroni correction was calculated based on the number of external measures. The 
calculations increased the significance level from 0.05 to 0.01. Standard multiple regression 
was conducted with each global measure as a dependent variable, and the SIPP-118 
domains that showed statistically significant correlations with the dependent variable at the 
p<0.05 level in bivariate analysis. Similar analyses were conducted for the CIP and SCL-90-
R subscales as dependent variables. The level of statistical significance was 0.05 for all 
regression analysis. To compare the SIPP-118 facet profiles in the patient samples from 
Norway and the Netherlands, and to measure differences between the sample profiles with 
different PD diagnoses, all facets were included simultaneously. Because the number of 
facets can be considered to be different measures, a two-group between-subjects 
multivariate analysis of variance (MANOVA) was used. 
For statistical power analysis in the comparison of OIP and CP, we used methods 
recommended for repeated measures design (Faul et al., 2007). With alpha level of 0.05 and 
a mean correlation among repeated measures of 0.35, we had a 95% power to detect an 
effect size of 0.26 reflecting the difference between the two treatments. The study applied 
an intention to treat approach. 
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Pre–post effect sizes were computed by Cohen’s d, using the pooled standard deviation and 
adjusting for sample size (Cohen, 1988).  
Reliable change was estimated to enhance the clinical relevance of the results comparing the 
two treatments. Reliable change is an estimate of change based on the reliability of the 
instrument and the standard deviation of the data (Jacobson & Truax, 1991). Because of the 
lack of test-retest reliability in our samples, the test–retest reliability estimates were based 
on the following studies: GSI = 0.86 (Groth-Marnat, 1990), CIP = 0.92 (Pedersen et al., 
2007b), GAF = 0.82 (Pedersen et al., 2007a), Quality of life = 0.79 (Pedersen, 2007a), Beck 
Hopelessness Scale = 0.85 (Holden & Fekken, 1988), BDI = 0.82 (Moffett & Radenhausen, 
1990), and SIPP-118 = 0.92–0.97 (Andrea et al., 2007). Differences in the number of 
patients showing a reliable positive or negative change in clinical measures in the two 
treatments, compared with patients who did not show any change, were tested by analysing 
2x2 frequency tables using Chi-square tests.  
In order to strengthen the validity of the efficacy studies, inferences were based on broader 
patterns of change, rather than single tests. To estimate differences between the treatment 
conditions at 8 months follow-up the sum scores from the clinical measures were entered 
into two-group between-subjects multivariate analysis of variance (MANOVA). In addition 
to this over all test, univariate ANOVA were used to estimate differences on each measure. 
Multiple logistic regression analyses were used to predict the occurrence of suicidal 
thoughts and self-injury at 8 months follow-up. The predictor variable was treatment 
condition (DHP and OIP), with suicidal thoughts or self-injury at baseline included as 
covariates to adjust for pre-treatment levels of these variables.  
To compare efficacy for subgroups of patients at 8 months follow-up, a selection of the 
most poorly functioning patients in the sample was extracted based on a combination of 
their capacity for work and the total number of fulfilled SCID II criteria at baseline. This 
subgroup yielded 26 patients (DHP: N = 11, OIP: N = 15). MANOVA statistics usually 
require about N = 20 in each of the four cells. Hence, independent sample t-tests for each of 
the clinical measures were used to test the differences in outcome between treatments for 
this subgroup of patients. 
For the comparison of the two treatments at 18 months follow-up, we used a General Linear 
Mixed Model (SPSS 16.0). The main advantage of the GLMM approach over standard 
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repeated multivariate analysis of variance is that it allows for inclusion of cases with 
missing values, thereby providing a better estimate of the true (unbiased) effect within the 
intention to treat sample. To examine the efficacy of the treatments, we used a model with 
time (three time points), treatments (CP and OIP), and time x treatment interaction. Each of 
the 13 clinical measures was used as dependent variables. The number of fulfilled SCID II 
criteria, and capacity for work or study prior to inclusion, were added as covariates to 
estimate the effect of initial differences in severity at baseline. To assess possible 
confounding impact of premature termination of treatment, termination before 18 months 
evaluation were also added as covariates. We used Compound Symmetry Heterogeneous as 
covariate type, as we expected same amount of dependability in covariates, and change in 
variations across time. Akaikes’ information criterion (AIC) was used to inspect the fit of 
the model. To explore if the number of specific PD criteria interacted with outcome in the 
two treatments we used the same GLMM approach with a model with time, treatment, and 
treatment x number of specific PD criteria interaction. The total number of fulfilled SCID II 
criteria was used as covariate.  
In the cost analysis the distribution of continuous variables was examined by comparing 
mean and normal probability plots (Q-Q plots). Bootstrapped confidence intervals based on 
2000 replicates were calculated due to higly skewed cost data, using the statistical package 
of STATA /IC 10.0 for Windows. The basic idea of bootstrap involves repeated random 
sampling with replacement from the original data producing random samples of the same 
size as the original sample. Each of these bootstrap samples provides an estimate of the 
mean. Repeating the process 2000 times, as in our paper, provides information of the 
variability of the estimator. A 95% confidence interval for the mean would then be values 
from 2.5% to 97.5% of this variability.  
3.6 Subjects 
Two hundred and fifty patients were referred to the Department of Personality Psychiatry 
during the intake period for the study (see Figure 2). Only patients with PDs were included 
in the study. 
Exclusion criteria  
Exclusion criteria were schizotypal PD, antisocial PD, ongoing alcohol or drug dependence, 
psychotic disorder, bipolar I disorder, untreated ADHD (adult type), developmental disorder 
(e.g. Asperger`s syndrome), organic syndromes, and being homeless. Of the 250 referred 
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patients, 117 met the entry criteria for the UPP. Three patients withdrew after the 
randomization procedure, and the total number of patients in the sample was 114.  
Figure 2: Number of patients participating in follow-up evaluation 
250 patients referred to specialized day 
hospital treatment for PD 
117 randomized  
133 patients excluded due to 
exclusion criteria, not having 
PD, or not attending 
evaluation 
3 withdrew after 
randomization 
114 included 
OIP 
N=54  
CP 
N=60  
OIP 
N=46 
CP 
N=58  
Baseline N=114 
8 months N=104 
OIP 
N=39 
18 months N= 88 CP 
N=49  
 
Completeness of data 
Of the 114 patients included in the sample, 104 (91%) attended the 8 months evaluation and 
88 (77%) attended the 18 months evaluation (see Figure 2). Eighty-three patients (73%) 
completed all three evaluations while 5% (4 CP patients and 2 OIP patients) completed only 
baseline evaluation. Four of these patients were diagnosed with APD at baseline, two of 
which had co-occurring BPD, one patient was diagnosed with PD NOS, and one with 
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obsessive compulsive PD. Five out of these six patients were female. As a group they 
obviously had more avoidant PD (APD) criteria than patients attending the additional 8 
and/or 18 months evaluations (mean = 4.3 vs. 2.5, F=4.53, p<0.05), they exhibited less 
dependent PD criteria (mean = 0.5 vs. 1.8, F=4.65, p<0.05), a lower experienced quality of 
life (mean = 2.5 vs. 3.5, F=4.61, p<0.05) and a higher score on interpersonal problems (CIP) 
(mean = 1.9 vs. 1.7, F=4.95, p<0.05). In addition, there was a non-significant trend on the 
various clinical measures suggesting that these patients perceived more severe impairment 
than patients attending evaluations. When comparing patients attending 18 months 
evaluation (N=88) and patients not attending 18 months evaluation (N=26) no such trend 
was found. There was only one statistically significant mean difference between these two 
groups. The patients not attending 18 months follow up had a higher CIP score (mean = 1.9 
vs. 1.6, F= 7.8, p<0.05). There were not found any statistical significant differences in 
reliable change on clinical variables at 8 months follow-up between the groups attending vs. 
not attending the 18 months follow-up.  
Patient description at baseline 
A complete baseline description of the sample is shown in Table 3. The 114 included 
patients had a mean age of 31 years (SD = 7.4), with the oldest patient being 54 years, and 
the youngest being 20 years of age. A high proportion of the sample was female (74%). 
Fifty percent of the patients had less than 12 years of education which is lower than average 
in Norway (http://www.ssb.no/ssp/utg/200605/05/tab-2006-12-11-01.html). About 38% of 
the patients lived alone, and 6% was married. Half of the patients were unemployed, and 
21% received support by the social welfare system. Very few defined themselves as home 
wives, or worked part time. Thirteen percent of the patients reported suicidal attempts 
during the last 12 months and 31 % reported self harming activities in the same period. 
Eighty-six percent reported suicidal thoughts during the last 12 months, while 50% reported 
suicidal thoughts during the last seven days. Mean GSI score was 1.7 (SD = 0.7), mean CIP 
score was 1.7 (SD = 0.5), mean BDI score was 19.1 (SD = 8.8), mean quality of life score 
was 3.4 (SD = 1.6) and mean GAF score was 47.6 (SD = 4.4). Seventy percent of the 
patients were using, or had been using psychotropic medication last 12 months.  
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Table 3: Sociodemographic and clinical characteristics of the 114 participants at 
baseline 
 Total (N=114) CP (N=60)  OIP (N=54)  
Age, Mean (SD) 31 (7.4) 31 (7.3) 31 (7.5) 
Women 74 % 77 % 72 % 
More than 12 years of education 50 % 41 % 57 % 
Marital status 
Live alone 
Live alone with children 
Live with parents  
Common law partner 
Married 
Other 
 
38 % 
12 % 
6 % 
12 % 
6 % 
26 % 
 
39 % 
10 % 
3 % 
12 % 
5 % 
31 % 
 
38 % 
13 % 
9 % 
11 % 
8 % 
21 % 
 
Work status 
Full time employee (100%) 
Half time employee (aprox. 50%) 
Student 
Unemployed 
Other 
 
23 % 
8 % 
16 % 
50 % 
3 % 
 
22 % 
12 % 
16 % 
50 % 
0 % 
 
24 % 
4 % 
16 % 
50 % 
6 % 
 
Self injury/suicide attempts 
Suicidal thoughts last 7 days 
Suicidal thoughts last 12 months 
Self harming activities last 12 months  
Self harming activities lifetime 
 
50 % 
86 % 
31 % 
48 % 
 
51 % 
88 % 
36 % 
50 % 
 
49 % 
83 % 
26 % 
46 %  
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Sixty-eight percent of the patients were diagnosed with one PD, 25% with two, and 7% had 
three or more co-occurring PD diagnoses. The distribution of the PD diagnoses (see Figure 
3) was as follows: borderline PD (46%), avoidant PD (40%), PD not otherwise specified 
(21%), paranoid PD (15%), obsessive compulsive PD (9%), dependent PD (7%), narcissistic 
PD (2%), and schizoid PD (1%). The mean number of SCID II criteria was 15.8 (SD = 6.4).  
Figure 3: Axis II diagnoses (%) 
Number of axes II diagnosis:
1: 67,5%     2: 25,5%     3: 7%     4: 1%
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The mean number of symptom disorders in the sample was 3.4 (SD = 1.4). Seventy four 
percent of the patients were diagnosed with Major depression, 37% with Dysthymia, 8% 
with Bipolar II disorder, 46% with Panic disorder, 47% with Social phobia, 12% with 
Obsessive Compulsive disorder, 48% with GAD, 27% with Substance misuse disorders, and 
14% with Eating disorders (see Figure 4).  
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Figure 4: Axis I diagnoses (%) 
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The data indicates a sample of patients with moderate to high level of impairment. There 
were no significant differences between the patients in the two treatment conditions at 
baseline concerning sociodemographic characteristics, clinical variables, or distribution of 
PD diagnoses and symptom disorders. 
The Dutch samples 
In the validation study of the SIPP-118 we used two Dutch samples from the initial studies 
of the SIPP-118 for comparison (Andrea et al., 2007). The first sample consisted of 478 
individuals from the general population, who participated in a postal personality survey. In 
total, 1520 general community subjects (50% females) from four age groups (15-24; 25-34; 
35-44; and 45-54 years) were randomly drawn from the patient files of 15 general 
practitioners from the Dutch cities and villages Amsterdam (735,500 inhabitants), The 
Hague (457,700), Tilburg (197,400), Groningen (175,600), Leiden (117,200), Heerlen 
(95,000), Kerkrade (50,700), Waddinxveen (26,900), Ermelo (26,800), Reusel (12,400), and 
Laren (11,900). These subjects received by mail several self-report questionnaires including 
the Severity Indices of Personality Problems (SIPP). Taking into account 35 booklets that 
were undeliverable, the response rate was 32.2%. Respondents were mostly female (67.6%), 
and had a mean age of 36.0 years with a standard deviation of 11.6. Educational level was 
low in 19.3%, intermediate in 49.1%, and high in 31.6%.  
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The second sample (N=555) comprised patients from six mental health care institutes in the 
Netherlands (Center of Psychotherapy De Viersprong, Halsteren; Altrecht, Utrecht; Zaans 
Medisch Centrum De Heel, Zaandam; Center of Psychotherapy De Gelderse Roos, 
Lunteren; GGZWNB, Bergen op Zoom; Center of Psychotherapy Mentrum, Amsterdam). 
These institutes offer outpatient, day hospital and/or inpatient psychotherapy for patients 
with personality pathology and/or personality disorders. As part of the standard intake 
procedure in these institutions, all admissions underwent a routinely distributed assessment 
battery including self-report questionnaires and a semi-structured interview to measure 
psychopathology, personality, functional impairments, and treatment history. Of these 555 
patients, 60.0% were female. The mean age was 33.9 years (SD=10.4, range 16-66). 
Educational level was low in 13.0%, intermediate in 59.5% and high in 27.5%.  
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4. Summary of papers 
4.1 Paper I: A cross-national validity study of the Severity Indices of 
Personality Problems (SIPP-118) 
The objective in this study was to test the validity of a new dimensional measure of 
maladaptive core pathology for Personality Disorders (PDs), the SIPP-118, by comparing a 
Norwegian sample of 114 patients with PDs with two Dutch samples. In addition, SIPP-118 
scores for patients with avoidant PD and borderline PD were compared, and the relationship 
between scores on the SIPP-118 and commonly used clinical measures were investigated. 
The results showed good psychometric properties of the SIPP-118 at the facet level. The 
Norwegian PD sample had scores equal to the Dutch PD sample and significantly below the 
general population sample. Correlations with other clinical measures were in the low to 
moderate range. An instrument measuring the core pathology of PDs has been requested in 
the area of research and clinical work with patients with PDs, and the results of this study 
supports a good cross-national validity of the SIPP-118. The instrument seems promising as 
a dimensional instrument for measuring core personality pathology, but the structure of the 
higher-order domains of the SIPP-118 should be confirmed in larger patient populations and 
the facet Respect should be reconsidered. Further studies should focus on the ability to 
differentiate between axis I and axis II populations. Moreover, the instrument’s ability as a 
measure of therapeutic change is not yet established and should be examined further. 
4.2 Paper II: Psychotherapy for Personality Disorders: Short-term day 
hospital psychotherapy versus outpatient individual therapy - a randomized 
controlled study 
This paper presents the results of the 8 month follow-up investigation from the UPP. The 
initial day hospital psychotherapy (DHP) was compared with outpatient individual 
psychotherapy (OIP) for patients with personality disorders (N = 114). The main outcome 
measures were attrition rate, suicide attempts, suicidal thoughts, self-injury, psychosocial 
functioning, symptom distress, and interpersonal and personality problems. The study 
showed a low dropout rate and a moderate improvement on a broad range of clinical 
measures for both treatments. However, there was no indication of the superiority of one 
treatment over the other. Neither was there any indication that day hospital treatment was 
better for the most poorly functioning patients. Further studies will follow this group of 
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patients for the next five years, the results of which may have implications for resource 
allocation and the organisation of mental health services for patients with personality 
disorders. To our knowledge, this study is the first RCT comparing short-term day hospital 
psychotherapy and individual psychotherapy in private practice for a mixed group of PD 
patients with a severe to moderate degree of impairment. Overall, the treatment conditions 
were assumed representative of day hospital treatment in Norway, as well as private 
psychiatry and psychology practice.  
4.3 Paper III: Psychotherapy for Personality Disorders: 18 month evaluation 
in the Ullevål Personality Project – a randomized controlled trial 
The paper presents the results of the 18 month follow-up investigation in the UPP. A step-
down model (CP) consisting of initial short-term day hospital treatment followed by 
conjoint group and individual outpatient treatment was compared with outpatient individual 
psychotherapy (OIP). A mixed group of patients with PDs (N = 114) with severe to 
moderate degree of impairment was randomized to the two treatment modalities. The 
patients were evaluated at baseline, 8 months and 18 months on a wide range of clinical 
measures assessing symptoms, interpersonal problems, psychosocial functioning and 
personality pathology. The main finding at 18 months’ follow-up was that the intensive, 
multimodal combined psychotherapy (CP) was not more effective than outpatient individual 
psychotherapy (OIP). On the contrary, there was a trend of better results in the OIP 
treatment. The study has to be supplemented with a cost-utility analysis before any 
consideration of implications for health care planning. However, as for efficacy, the study 
indicates that eclectic psychotherapy provided by private practitioners has an equal or better 
effect upon patients with PDs compared to the more comprehensive day hospital and 
outpatient follow-up treatment. 
4.4 Paper IV: Health service utilization costs for patients with PDs treated 
with combined psychotherapy versus individual psychotherapy – 18 months 
follow-up in the Ullevål Personality Project  
Follow-up studies from the UPP have not revealed major differences in effectiveness 
between the long-term treatment consisting of initial short-term day hospital followed by 
conjoint group and individual treatment (CP) compared to individual outpatient treatment 
(OIP). Thus, costs analyses of the treatments are important for both clinical and political 
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decision-making concerning patients with personality disorders (PDs). This paper examines 
the costs of treatment, additional health related services, and medication for patients in the 
two treatment conditions at 8 and 18 months follow-up (N=114). The main finding was that 
the higher treatment costs for initial day hospital treatment in CP were compensated by a 
reduction in costs in the use of additional health services. The total costs for patients in CP 
were equal to the total costs for patients in OIP at both 8 months follow-up and 18 months 
follow-up. The results emphasise the need for taking additional health care utilization costs 
into account when making treatment decisions for patients with PDs. 
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5. Discussion 
The importance of an instrument assessing core PD pathology is emphasised in both 
research and the clinic. The study of the newly developed SIPP-118 is the first validity 
study outside the original developmental studies. The results may have significance for 
establishing a focus on the dimensionality of PD pathology in the clinic as well as 
strengthening the internal validity in efficacy studies in general, and in the UPP specifically. 
Thus, strengths and limitations of the SIPP-118 study needs to be addressed. 
The UPP is to our knowledge the first RCT comparing initial short-time day hospital 
psychotherapy followed by long-term conjoint therapy (CP) with individual psychotherapy 
in private practice (OIP) for a mixed group of patients with PDs. The main findings from the 
present studies were that the extensive combined psychotherapy (CP) was not more 
effective than outpatient individual psychotherapy (OIP). These results were present for all 
main clinical measures, including the newly developed measure of core personality, the 
SIPP-118, attrition rate and health utilization costs during treatment. The results may have 
implications for resource allocation and the organisation of mental health services for 
patients with PDs. Thus, both the internal validity and the external validity of the study need 
to be discussed. Internal validity refers to the degree of difference in content of the two 
treatments, to what degree the results in these studies can be attributed to the treatments in 
question, and to what degree the measures are able to measure clinically important aspects 
of the patients change. External validity refers to in what degree the results can be 
generalized to other samples and settings.  
5.1 Methodological issues 
Participants 
One of the strengths in the UPP was the thorough diagnostic procedures at baseline, and the 
various PD diagnoses in the sample. When evaluating the SIPP-118, the variation in PD 
diagnoses increased the possibility to evaluate the instrument as a measure of core 
pathology cutting across the different diagnostic categories. A limitation in the validation 
study of the SIPP-118 was the lack of a Norwegian normal population. Although the 
Netherlands may not be culturally very dissimilar to Norway, further studies of the SIPP-
118 should compare different Norwegian samples. In addition to a Norwegian normal 
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sample, a population with only axis I symptom disorders as well as patients with supposedly 
more severe PD disorders should be included. 
The randomization of the patients in the UPP was regarded as successful. The patients in the 
two treatments were comparable at baseline with respect to the distribution of sex, 
sociodemographic variables, symptoms, interpersonal and personality problems, 
psychosocial functioning and diagnoses.  
The overall completion of data was high considering the patient population (91% at 8 
months, and 77% at 18 months), but characterisations of the patients not attending follow-up 
evaluations might still have affected the results. It is interesting that the six patients only 
attending baseline evaluation exhibited more avoidant PD criteria, less dependent PD 
criteria, higher scores on interpersonal problems (CIP), and a lower experienced quality of 
life than patients attending the additional 8 and/or 18 months evaluations. This patient 
profile indicates a challenge with regard to forming a therapeutic alliance. Moreover, the 
higher rate of patients in CP attending follow-up evaluations compared to OIP patients 
might point to an advantage for the CP treatment where a therapeutic bond was already 
initiated during the intake interviews as these were located at the Department of Personality 
Psychiatry. This could have influenced the short-term results in favour of DHP, although 
this was not evident in the results at the 8 month follow-up. The difference in attending 
follow-up evaluations may also be explained by the CP patients forming a relationship with 
the institution as a whole throughout the initial day hospital treatment, thus feeling more 
responsibility for meeting to evaluations. On the other hand, the missing patients might have 
deteriorated, or might have experienced lesser change than the patients attending follow-up 
evaluations. The GLMM approach does not fully account for possible attrition bias, 
although meeting for evaluation was added as a covariate in the analyses. As such, the 
difference in attendance at follow-up evaluations may conceal differences in efficacy which, 
despite the intention to treat design, is regarded as a limitation of these studies. 
The patient sample was not restricted to a specific personality type, but contained different 
PDs, mostly patients with BPD, APD and paranoid PD with various co-occurring PDs, in 
addition to PD NOS. This is considered a strength, as other studies comprise patients with 
mainly BPD. On the other hand, the patient sample did not include the entire spectre of PDs. 
The lack of patients in Cluster A limits the generalisation of the results, but the PDs in our 
study are being fairly representative of “typical” PD patients who is present at mental health 
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centres in small and large cities, and in rural areas (Narud et al., 2005). The study sample 
contained more patients with BPD than in the Norwegian Network of Psychiatric Day 
Hospitals (the “Network”) as a whole (46% versus 23%, N = 2248, Geir Pedersen, personal 
communication). However, the study sample was not more dysfunctional on clinical 
measures at admission than patients in the “Network”. 
The PD patients in the study had a severe to moderate level of impairment. Thus, they were 
not as severely disturbed as the patients in the Bateman and Fonagy study (Bateman & 
Fonagy, 1999). In their study of an 18 months day hospital treatment program, the patients 
had a mean GSI of 2.5 (SD = 0.58) at baseline evaluation as opposed to our sample where 
the mean GSI at baseline were 1.7. The patients in the UPP were more similar to the patients 
in the Giesen-Bloo study (Giesen-Bloo et al., 2006) and the Davidson study (Davidson et 
al., 2006b) both regarding symptom load and level of psychosocial functioning. In these two 
studies the patients received outpatient individual treatment. If severity is an indicator for 
the choice of treatment modality for PD patients, our results with the lack of difference in 
efficacy between treatments may indicate a sample of patients with a level of impairment 
where some patients might respond to more intensive and structured treatment while others 
might respond to less extensive treatment. Hence, a mix of PD diagnoses and severity for 
patients included in the study might neutralise a possible difference between the two 
treatments. On the other hand, the argument of better effect from the more structured 
treatment for the most severe patients, should lead to a difference when comparing 
subgroups. The most poorly functioning patients would be expected to show more 
improvement in CP while the better functioning patients would be expected to show more 
improvement in OIP. That was not the case in our study.  
Most studies on PDs are specialised treatments for BPD patients. Arguments for the 
“general” type of CP treatment evaluated in the UPP, in contrast to specific treatment 
programmes for self-destructive borderline patients, have been that the “general” CP model 
can be applied “everywhere”, while specialised treatment programmes directed at specific 
PDs require a larger catchment area. Although the patient sample in the UPP was relatively 
large compared with other RCTs in this field, the number of patients was low when 
analysing subgroups (as with severity and differences between diagnostic groups) and 
variables with low frequency (as with self-destructive behaviour).  
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Treatments 
It is important to emphasise that the aim of the UPP was not to compare specific treatment 
techniques. Rather, the outcome studies compared modes or formats of treatment that 
corresponded to psychotherapy as it has been generally practiced in Norway, both in day 
hospitals and in private practice. Thus, an important question is how representative these 
conditions were. Compared with the 12 units in the Norwegian Network of Psychiatric Day 
Hospitals, the DHP was representative in most of its important characteristics (e.g., short-
term format of 18 weeks, group therapies only, number of treatment hours a week, general 
ideology). A common practice for other day hospitals would be to offer continuation 
treatment using a group psychotherapy format only, which would be accepted by 
approximately 50% of the patients. The present study offered conjoint group and individual 
treatment as continuation treatment, with the expectation that all patients would attend such 
treatment. During the study, the staff complained that they were “not allowed” to be as 
confrontational as they would otherwise have been, in order to avoid dropouts and to 
promote the development of attachment. This was one of the elements which were 
introduced in the written guidelines. In addition, problems with the research logistics meant 
that the groups were rather small at times and, as a consequence, even more vulnerable to 
the effects of poor attendance, which affected the group dynamics. The staff felt obliged to 
proceed with patients who otherwise would have been regarded as poor candidates for 
continuation group treatment based on evaluations made at the end of the day hospital 
treatment. The accepted practice assumed an attachment to “the institution as a whole”, 
which tried to compensate for possible separation trauma after 18 weeks initial day hospital 
treatment by ensuring that patients would meet a staff person whom they knew in the 
following outpatient conjoint treatment (but to whom they were not necessarily attached) as 
the continuation group therapist. Overall, the experiences of the DHP staff indicated that 
they were a little more frustrated than usual, they felt somewhat less competent, the 
completion rate was perhaps artificially high, and the group dynamics were somewhat more 
difficult. Since group cultures and dynamics fluctuate in day hospitals, and there are some 
“natural” ups and downs, the culture that was studied was possibly in the lower to middle 
range of an average day hospital programme. 
In OIP, all psychiatrists and clinical psychologists (N = 32) worked in private practice and 
had a contract with the State Health Insurance Fund, which implies that patients pay a 
maximum of approximately €200 per year, irrespective of how much therapy they receive. 
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There is no restriction on the number of years spent in treatment. Most OIP therapists in the 
study proved to be experienced and well qualified. After patient randomization, they 
received a comprehensive evaluation report of the patients they were to treat, which 
contained anamnestic information, diagnoses, evaluation of personality functioning and test 
results. Some therapists reported that the initial phase of treatment was influenced by the 
patient’s dissatisfaction with being allocated to the OIP. In general, the OIP therapists 
expressed satisfaction with the project as a whole, and welcomed this opportunity to partake 
in a scientific study. They felt the project to be a good opportunity to demonstrate that 
private practice is a sound and efficient alternative to more costly treatments. Our 
impression was that the private practitioners were highly motivated, and possibly in the 
upper range with respect to experience and qualifications. Their “psychotherapy as usual” 
approach, in this case, implied that they exhibited more than the usual tolerance with respect 
to cancelled sessions and payment problems. In summary, it is reason to believe that their 
services were in the upper range of what could be considered “psychotherapy as usual” in 
the community. 
Methods 
Design 
One of the main strengths of the UPP was that the efficacy studies reported was completed 
according to the Cochrane review’s recommendations of RCTs and intention to treat design 
(Marshall et al., 2001). The RCT procedure should ensure similarity in the two patient 
samples on most variables, which was also found when testing the samples at critical 
baseline characteristics. RCTs have been criticised for low external validity, that is, the risk 
of studying conditions that are not representative of clinical practice (Seligman, 1995). 
However, our RCT comparing modes or formats of treatment that were assumed to be fairly 
representative of day hospital treatment in Norway, as well as private psychiatry and 
psychology practice, supports generalizability, and meet modern scientific standards.  
The study can be criticised for its lack of a no-treatment group, so that, strictly speaking, the 
design cannot attribute change to the treatment conditions. The observed change in both 
conditions may reflect factors such as “a natural recovery process” (Perry et al., 1999; Shea 
et al., 2002), or a regression towards the mean effect. However, for this patient population 
with a GAF level of less than 50, a “no-treatment condition” is not realistic. In modern 
Western health care systems, and particularly in the Scandinavian type of welfare state, a 
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host of other treatment and care facilities could have been called upon for assistance. The 
real question is whether a “treatment as usual” (TAU) group should have been included. 
Based on previous knowledge of the effect of psychotherapy for patients with PDs 
(American Psychiatric Association, 2001; Bateman & Fonagy, 2001; Leichsenring & 
Leibing, 2003b; Perry et al., 1999), allocating patients at random to a TAU group after five 
to eight hours of assessments, which also included assessment of motivation, was regarded 
as being unethical. The ethically sound and realistic alternative to the initial day hospital 
treatment, which was regarded as “day hospital treatment as usual”, was “psychotherapy as 
usual” in Oslo. This was a treatment option which existed “out there”, but which these 
patients did not often consider because of personal and systemic difficulties.  
The logistics when starting up the project was challenging. Two hundred and fifty patients 
were referred to the Department of Personality Psychiatry, mostly from mental health 
centres, and were allocated to one of the treatment conditions successively. By 8 months 
evaluation all patients in OIP had been referred to a therapist and the mean duration of 
treatment was 4.5 months. Several patients had to wait several months before starting 
treatment. The delay was due to a number of factors; some patients were referred just before 
summer holidays, were hospitalised before starting treatment, did not meet, or the therapist 
did not have the possibility to start treatment right away. The same logistic challenge 
occurred in CP which resulted in few patients in the DHP group treatment at times. If the 
waiting period before initial DHP lasted more than 3 months, the patient was asked to fill 
out the self-report questionnaires again, as to control for possible changes during this period. 
These are conditions which are difficult to control for, and should be taken into 
consideration when interpreting the results.  
One might question the choice of time for the 8 months follow-up evaluation. A 6 months 
follow-up would have been beneficial in comparing results with e.g. the Bateman study 
(Bateman & Fonagy, 1999). On the other hand, taking into account the complicated logistics 
(e.g. to be sure that all DHP patients had ended short-term treatment, and that all OIP 
patients had been in treatment a reasonable amount of time before follow-up evaluation), 8 
months follow-up was decided. 
After the initial day hospital treatment, patients in CP were confronted with the challenges 
of both separation and forming new attachment relationships as there was a transition to the 
conjoint outpatient treatment. For most CP patients the 8 months evaluation took place 
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during or just after this transition phase. A previous study indicated that this period, with all 
of its dynamic implications, is a difficult and vulnerable phase (Hummelen et al., 2007). 
Thus, it might be a period where the CP patients experienced increasing symptoms. The OIP 
patients had the benefit of continuing their treatment with the same therapist.  
One argument for the use of short-term treatment has been a reduction in the risk of patient 
regression, and it can be speculated whether the short-term format revives affect and 
relational problems without allowing enough time for the patient to work constructively on 
these problems. Instead, while a stable relationship with the therapist or group would be 
essential for working through the arising relational problems, the transition phase may be 
experienced as the breaking of therapeutic bonds, and would not be beneficial. On the other 
hand, a heightened awareness of relational problems for patients who have adopted 
strategies for avoiding relational challenges might be necessary for working through these 
problems.  
Assessments 
The instrument package was extensive comprising both symptoms measures, measures of 
interpersonal functioning, measures of psychosocial functioning, and measures of 
personality pathology. In addition, both self-report and interviews were used as methods. In 
total, these assessments should be beneficial for detecting changes and possible differences 
between the treatments. 
On the other hand, unreliable measures could lead to concluding that relations between 
treatment and effect does not exist when they actually does (Type II error). With respect to 
the studies in the thesis, the reliability of axis I and axis II diagnoses is of importance. Since 
the introduction of DSM-III in 1980, much research effort has been put in valid 
classification of personality disorders, and a tremendous amount of literature has been 
written on treatment according to these categories. Studies have shown that individuals may 
fluctuate around a general level of personality pathology leading to movements below or 
above a specific threshold over time. Thus, despite the clinical utility, existing diagnostic 
categories may not in fact be tremendously helpful to clinicians (Livesley, 2001; Verheul, 
2005). Many investigators have noted that a categorical classification system may not be 
optimal for diagnosing personality disorders, and that PDs is better conceptualised 
dimensionally. However, there is still considerable debate about which dimensional system 
is the best option, or if different systems can be hierarchically organised within the same 
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diagnostic manual (Widiger & Simonsen, 2005). As for today, DSM-IV PDs are mostly 
conceptualised by reflecting combinations of traits rather than the extreme of a single 
personality trait dimension. As such, with a threshold of five criteria for BPD, there might 
not be any significant clinical difference between a patient fulfilling any four BPD criteria 
and a patient fulfilling five. This is of course unfortunate with respect to group comparisons 
based on diagnostic status. To increase the validity and reliability of the different diagnoses, 
there was a strong focus on the assessment process in UPP where the evaluators followed 
specific procedures. Strictly, patients do not have a disorder, they are found to meet the 
criteria defined in the diagnostic system and judged to warrant the disorder. 
The reliability of axis II diagnoses at baseline evaluation was acceptable, although in the 
low range compared to other studies (Zanarini & Frankenburg, 2001). This was probably 
partly due to information bias. The evaluator gathered anamnestic information, had a written 
referral, and received information from carrying out the MINI interview in addition to the 
SCID II interview, while the independent rater scored only from the videotaped SCID II 
interview. To judge whether the patient meets each of the criteria is not easily assessed, and 
the medium axis II reliability may also be due to the potential confusing effects of axis I 
states as the majority of the patients included in the study were diagnosed with a co-
occurring axis I disorder (e.g. 74% were diagnosed with major depressive disorder). The 
axis I reliability was low, which might also point to the difficulty in differential diagnostics. 
The low to medium reliability of the diagnoses could have affected the results in the 
comparison between diagnostic categories in the SIPP-118 paper as the conclusion of SIPP-
118 as a valid instrument for assessing core pathology is based on the reliable difference of 
APD and BPD diagnoses in the sample. 
There is a lack of valid measures for assessing severity and core personality pathology in the 
PD field. Such a measure of “core pathology” should preferably be based on clinical theory 
of personality development, and focus on impaired adaptive capacities and common 
dysfunctions cutting across the existing diagnostic categories. Furthermore, it should be a 
dimensional measure sensitive to treatment changes. Obviously, a self-report format is less 
labour consuming and would enhance its clinical utility. SIPP-118 was such an instrument, 
although it had not been validated outside the initial developing studies, and there was no 
Norwegian version available. The challenge with the external validation of the SIPP-118, as 
with other attempts to make dimensional measures of severity, is the lack of consensus on 
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how to validate severity. In our study we compared clinical samples with a normal sample; 
we used a variety of the most commonly used clinical measures for relational-, symptoms- 
and general psychosocial functioning. In addition, we used the number of fulfilled SCID-II 
criteria as a validation measure. The low correlation with the number of fulfilled SCID-II 
criteria may have a few possible explanations. Firstly, the number of SCID-II criteria may 
be a poor measure of severity as the SCID-II criteria differ widely in content. Some criteria 
points to life threatening events such as suicide attempts and drug abuse whereas other 
criteria is defined by lack of close friends or being easily influenced  by others. As such, one 
could debate the unidimensionality of this scale as a measure of severity. In addition, one 
might question the number of SCID-II criteria as a valid measure in our study, but the high 
reliability scores referred is contrary to such a conclusion. On the other hand, the restricted 
range of the SCID-II criteria found in this sample may affect the size of the correlations. 
Finally, the low correlation may indicate that the SIPP-118 is a poor measure for assessing 
severity.  
Another way of using diagnoses to address PD severity has been to regard certain PD 
categories or clusters as more severe than others, summing up the number of PD diagnoses, 
or a mixture of these two (Skodol et al., 2005a; Tyrer, 2005). Unfortunately we did not have 
a wider distribution of diagnoses, as we then additionally could have compared SIPP-118 
with these attempts to address severity. These issues should be elaborated in further 
explorations of the instrument. 
Statistics 
According to Shadish, Cook and Campbell (Shadish et al., 2002) “statistical conclusion 
validity concerns two related statistical inferences that affect the co-variation of causal 
inferences: 1) whether the presumed cause and effect co-vary, and 2) how strongly they co-
vary” (p.42). As to the first of these inferences, we can conclude that the relation exist in the 
sample when it actually don’t (type I error). On the other hand, we can conclude that it 
doesn’t exist when it actually does (type II error). Regarding the second inference we can 
overestimate or underestimate the magnitude of the relation, as well as the degree of 
confidence in our results. There are several threats to statistical conclusion validity, some of 
which have already been addressed, such as reliability of measures, missing data and 
regression to the mean effects. In addition, low statistical power and restriction of range can 
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lead to type II error, and high statistical power or extraneous variables can lead to type I 
error as well as overestimation of magnitude.   
With respect to the studies in this thesis some concerns are to be noted. Although the study 
sample was larger than in most comparable studies, the number of patients restricted the 
statistical methods used. This was especially evident in the SIPP-118 paper where factor 
analysis would have been useful for reconfirming the facets and higher order domains found 
in the original studies of the instrument. Generally, the medium size sample could increase 
the possibility for type II error in all the papers. Power sensitivity analysis recommended for 
repeated measures design was applied for the efficacy studies (Faul et al., 2007). The 
estimation showed a 95% power to detect an effect size of .24-.26 reflecting the difference 
between the two treatments. From this follows that small differences between treatments 
would not reach significance. In our results there was a trend towards better efficacy in OIP. 
With a larger sample this trend might have shown statistical significance, although the 
clinical significance would probably remain low. Of more concern for statistical validity 
was the restricted range seen in some variables due to the inclusion criteria for the study. 
The highly skewed data in occurrence of self-injury and suicide attempts, symptoms which 
are often seen as an essential part of focus for PD treatments, contributed to an uncertainty 
in efficacy regarding these variables. In addition, the limited range in the total of fulfilled 
SCID-II criteria might have decreased its validity as an external measure for severity in 
paper I with the lack of correlation with the SIPP-118 as a result. Similarly, as most of the 
statistical procedures used in the studies are dependent of the variance in the data, the 
restricted range in most of the symptom variables, GAF and PD criteria increases the 
possibility for type II error. Thus, the external validity gained by the sample in this study 
might reduce the statistical conclusion validity.  
The skewness of the health utilization data yields important information and is clinically 
interesting, but it also affects statistical procedures and interpretation. Some patients 
reported costs due to use of health services which was very high, up to €200.000 the year 
before inclusion, while others reported costs as low as €200. Long-term inpatient stays at 
somatic hospital due to e.g. heart transplantation was the main reason for the high costs for 
some patients. Therefore, somatic hospital was excluded from the analysis although one 
may argue that somatic illness and PD may be related, especially if patients were admitted 
to somatic hospital because of suicide attempts or intoxication. Even though costs related to 
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somatic hospital was excluded, there were still some high cost services, and high cost 
patients, which may have influenced the results when comparing the two treatments. Further 
studies should include larger samples to make subsample analyses possible.  
Because of the skewness of the health utilization data we used the bootstrap procedure to 
produce means and confidence intervals. One main assumption in the bootstrap procedure is 
that the missing values in the dataset are completely at random. This is a strong assumption 
and unlikely to hold for the data in our study. On the other hand, one advantage of bootstrap 
compared to traditional transformation of data is that we can interpret on the original scale 
and that in transforming data only approximate normal distributions will appear (Cantoni & 
Ronchetti, 2004). In addition, it has been argued that the relatively simple assumptions 
required for estimating a valid bootstrapped mean is to be preferred in the analysis of health 
cost data (Walters & Campbell, 2004).  
As for the efficacy studies, a common assumption in psychotherapy research have been that 
change is gradual and linear. The research designs and statistics used to study change often 
reflect this assumption. There has been criticism against this assumption and also the fact 
that the hypothesised predictors of change are measured once or twice and then compared 
between groups or correlated with symptom change at the end of treatment (Hayes et al., 
2007). Most research focuses on group averages, with much less emphasis on the rich 
information available in individual time course data. Traditional pre-post designs provide 
only snapshots of the change process, and traditional correlation and ANOVA-based 
analyses are limited in the extent to which they can capture discontinuities. An example of 
discontinuity analysis in PD treatment is reported by Strauss and his colleagues (Strauss et 
al., 2006). In their treatment study of patients with avoidant PD and obsessive-compulsive 
PD, they found that a worsening in the alliance followed by an improvement (a “rupture-
repair” episode) predicted improvement in personality disorder symptoms and depression. 
In the UPP, some of these constraints were met by collecting different kinds of data and 
having two follow-up evaluations, although all analyses used in the studies were based on 
linearity and the results reported were based on average change in the two treatment 
samples. In addition, we analysed subsamples to explore whether patients with more severe 
pathology showed a different pattern of change than the patients with less severe pathology 
at the 8 months follow-up. Unfortunately, the number of patients was too low to extend 
these subsample analysis, and three assessment points are not adequate for more thorough 
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analyses of discontinuity or individual fluctuations in change. The lack of such process 
measures and statistical procedures might be a limitation of the present studies, and should 
be subject for further exploration throughout the UPP period. 
Summary of the methodological strengths and limitations 
The validity study of the SIPP-118 had some limitations regarding lack of Norwegian 
normal population and samples with only axis I disorders. The comparison to the Dutch 
samples showed promising results for the Norwegian translations, but the validity of the 
instrument has to be reviewed further in larger and more diverse samples. 
The efficacy studies contained an extensive range of assessments enable to measure 
differences and changes in the two treatments. The number of patients was acceptable, and 
the number of patients meeting to evaluations was considered high. Hence, the statistical 
power for detecting changes and differences between treatments was considered good. The 
studies lacked a comparison group from a no-treatment condition. This was considered both 
unethical and unrealistic, but it reduces the interpretation of the estimated change as solely 
due to the treatments in question. The treatments were considered quite similar to realistic 
treatment conditions for PD patients in Norway. Thus, the results may be generalizable to 
Norwegian settings, although this external validity might have decreased the statistical 
conclusion validity.  
In examining the cost of treatment, the highly skewed distribution of the use of additional 
health services, making very broad confidence intervals, could have affected the possibility 
to find differences between treatments. In addition, the lack of differences in effect between 
treatments was a hindrance for cost-effectiveness analysis. On the other hand, the results 
give valuable information of taking additional costs into account when making clinical 
choices of treatment modality for patients with PDs.  
5.2 Discussion of the results  
Measuring core PD pathology 
SIPP-118 is a long sought for assessment designed for measuring the core pathology of PDs. 
The structure and validity of the instrument showed promising results in the original paper 
by the designers (Verheul et al., 2008). The results from the study of the translated 
Norwegian version of SIPP-118 were comparable with the Dutch results. The PD group 
from Norway showed an almost similar profile as the Dutch PD group and differed 
 
 
69 
significantly from the Dutch normal population group on the facet level. The reliability was 
good on all five domains and most facets. Thus, with some adjustments the psychometric 
qualities seems promising for the Norwegian version of this instrument. On the other side, 
both the Dutch study and our study can be criticised for not making a distinction between 
axis I and axis II. Thus, the question concerning the instruments ability to differ between 
personality problems and general psychiatric disorder is still not answered satisfactory. The 
present study did not comprise a large enough sample to replicate the factor structure of the 
five higher order domains, and this should be a focus for further studies. 
Additionally, one main focus when developing an assessment of personality pathology has 
been the ability to measure change. Normal personality has been viewed as stable and 
robust, and assessments have been focusing more on the stability of personality than on the 
ability to change. Introducing adaptive capacity as the core of PD pathology anticipates a 
heightened ability to capture change as the focus on heritability and generic personality 
traits is reduced. Paper I evaluated the validity of the SIPP-118, and further studies should 
evaluate the instruments ability to measure change.  
Another factor of importance when evaluating a new instrument is the clinical utility. SIPP-
118 is designed to be both an instrument used in research evaluating treatments, and to be of 
help in everyday clinical life working with PD patients. For clinical use, the fact that the 
instrument is built upon a theoretical foundation is considered a strength. The way SIPP-118 
emphasises the strengths in the individuals adaptive capacity along with weaknesses, may 
also be useful when making individual plans and making treatment decisions. The ability to 
measure change, and to distinguish axis I from axis II is also considered important for the 
clinical utility. In addition, the questions of cut-off scores to distinguish between clinically 
significant pathology vs. normality, and if different SIPP-118 profiles can predict outcome 
of different treatments are still unexplored. More studies are needed to explore the potentials 
of SIPP-118 as a useful instrument. If SIPP-118 is to be applied as a screening tool, one sum 
score instead of five might increase its clinical utility. The Dutch research group has 
developed a short form of the SIPP-118 (SIPP-SF) for research purposes. This version 
might hold some of the qualities mentioned above, but the SIPP-SF has to our knowledge 
not yet been tested in clinical studies.  
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The effect of short-time treatment 
At 8 months follow-up, change on clinical measures ranged from small to medium in both 
treatments (DHP: mean ES = .44 / OIP: mean ES = .36). Thus, the patient sample as a whole 
showed improvement over time, but there were no significant differences between 
treatments. According to our original hypotheses we expected that CP would be more 
beneficial even in the short run. This may have been an overly optimistic view as seen in the 
subsequent reflections, although the results from the 8 months follow-up were in the lower 
range compared to unpublished data from the Norwegian Network (N= 2248, Pedersen, 
personal communication). But even if the effect sizes were moderate, and there was no 
difference between treatments, there was a significant total change which is not to be 
underestimated. For comparison, the effect sizes for change measured by SCL-90-R in 
Bateman and Fonagy’s study (Bateman & Fonagy, 1999) was ES = 0.18 at 6 months follow-
up and ES = 0.51 at 12 months follow-up.  
Of course, as already mentioned, one cannot be sure that the changes reported at the 8 
months follow-up were due to specific effects of the two treatments, but the results were 
promising for the following evaluations. About one third of the total sample reported 
positive reliable changes on clinical measures at 8 months follow-up, whereas about one out 
of ten patients reported negative changes. These results were evident in both treatments. 
Even if there was a trend of positive change, the results also emphasise the importance of 
being aware of possible iatrogenic effects (Fonagy & Bateman, 2006). An important 
question was whether the patients who showed deterioration on clinical measures would 
continue this negative trend, or whether the increase in symptoms and interpersonal 
problems represents a temporary state on the way to a more positive development. In the 
study of Bateman and Fonagy (Bateman & Fonagy, 1999) the main effects in the partial 
hospitalisation group took place at 12 months follow-up and onwards. This supported a 
hypothesis of larger effects in the UPP at the 18 and 36 month follow-up.  
The lack of difference in dropout rate between treatments at 8 months follow-up was 
counter to our hypothesis. The drop out rate in both groups was quite low (13.5% in DHP 
and 7.5% in OIP) compared to other studies (Leichsenring & Leibing, 2003a; Ogrodniczuk 
& Piper, 2001; Verheul & Herbrink, 2007). A multicentre study of day hospital treatment 
programs in Norway (Karterud et al., 2003) reported an average dropout rate of 24%. The 
drop out rate in DHP in our study was well below this level, and two of the premature 
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terminations were actually not dropouts in a traditional sense. These two patients terminated 
due to advice from the therapists since they were re-diagnosed as having Asperger`s 
syndrome and organic frontal lobe syndrome (being wrongly assessed as avoidant PD). On 
the other hand, one might speculate if the drop-out rate was artificially low. The therapists 
were instructed to be more outreaching than their usual practice, which might have had an 
impact of the group culture, and thus may have had a negative impact on the treatment 
results. 
Even more notable is the low dropout rate in the OIP treatment. Containment/alliance versus 
rupture/dropping out is a crucial factor in the treatment of patients with PD, and high 
dropout rates have been used as arguments against individual psychotherapy for patients 
with PDs (Giesen-Bloo et al., 2006; Linehan et al., 2006). Additionally, in intention to treat 
analysis dropouts tend to have a significant impact upon treatment results (Giesen-Bloo et 
al., 2006; Linehan et al., 2006). One possible explanation might be the flexible format of the 
OIP. Therapists were not forced to do any specific treatment, but were allowed to work 
according to their own preference and attuned to the most pressing needs of the patients. Of 
course, cautious must be taken when comparing dropout rate between studies due to 
different definitions of dropout, different procedures, and duration of treatment and follow-
up periods (Shea et al., 1990), but this issue stands out as an important area for further 
exploration.  
The effect of long-time treatment 
The main finding in the 18 months follow-up evaluation was that the more intensive, 
multimodal combined psychotherapy (CP) was not more beneficial in terms of efficacy than 
outpatient individual psychotherapy (OIP). On the contrary, there was a trend towards better 
results in the OIP treatment. The results are consistent with one other study suggesting that a 
higher intensity of treatment dose might not yield significant additional effects, although 
this study compared inpatient treatment with a step-down model (Chiesa et al., 2004).  
The termination rate was equal in the two treatments, and there was only one modest 
interaction effect between type of PD and type of treatment (in favour of OIP). The overall 
changes was in the moderate to high range (CP: mean ES = .51 with a range from ES = .27 - 
.92 / OIP: mean ES = .71 with a range from ES = .31 – 1.05). For comparison, Bateman and 
Fonagy (Bateman & Fonagy, 1999) found an effect size on SCL-90-R of ES = .56 after 18 
months of mentalization based treatment for BPD patients (Bateman & Fonagy, 1999). In a 
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study of DBT versus community treatment by experts (CTBE) for BPD patients, changes on 
the Hamilton rating scale for depression were reported as ES = .93 (CTBE: ES = .61) at 12 
months and ES = .1.19 at 24 months (CTBE: ES = .88) (Linehan et al., 2006). Patients in a 
CBT treatment study showed  a change of ES = .81 on a symptom scale after 24 months of 
treatment (Davidson et al., 2006b; Davidson et al., 2006a), while Giesen-Bloo and 
colleagues reported ES = 2.02 on a mixed symptom scale at 3 years follow-up in a study of 
individual SFT for BPD patients (Giesen-Bloo et al., 2006). Although the overall effect 
sizes in our study was in the moderate to high range, and termination rate was comparable to 
other studies (Leichsenring & Leibing, 2003a; Ogrodniczuk & Piper, 2001; Verheul & 
Herbrink, 2007), the lack of difference between treatments was not in accordance with our 
hypotheses and was counterintuitive given the more intensive CP format. At 8 months 
follow-up we proposed various possible reasons for the lack of difference between 
treatments. One reason might be the transition phase after day hospital treatment, another 
might be that the intensive DHP stir up affects, and finally that a difference in change may 
be apparent in the long-term. One could argue that 18 months are still not long-term, but 
according to the reported development in treatment effect in other studies (e.g. Bateman & 
Fonagy, 2008b; Giesen-Bloo et al., 2006), a difference between treatments should be 
apparent after 1 ½ year of psychotherapy. The methodological limitations already discussed 
should of course be taken into consideration, but one might infer from these results that the 
decision of treatment modality for PD patients should be taken based on cost or availability 
considerations as the effect of the treatments is similar. But, before drawing such a 
conclusion, there are some important issues to address regarding the findings described.  
First, all evidence based methods for PDs are highly structured, and there has been proposed 
that the coherence and structure of the therapy has more impact on efficacy than treatment 
theories. On the other hand, the structure of the CP treatment may have been negative for 
some patients. The initial extensive treatment requires that patients who are employed get a 
sick-leave for the treatment period, possibly withdrawing from important structures in their 
lives that could be important for their social functioning.  
Furthermore, our study showed that almost 1/3 of the patients chose to end treatment before 
the 18 months follow-up independent of treatment allocation. This result raises a discussion 
of the benefit, or need, of long-term treatment per se, and illustrates the difficulty in 
maintaining treatment alliance in the work with PD patients. Many theories and treatment 
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models for patients with PDs have asserted long-term treatment as necessary for these 
patients. Long-term treatment has been supported by treatment studies, studies of the natural 
course of the disorder, as well as being implemented in the practice guidelines for BPD 
(American Psychiatric Association, 2001; Bateman & Fonagy, 2008b; Paris, 2002; Perry et 
al., 1999). On the other hand, short-term treatment for patients with PDs has also shown 
good results, even though these studies have been criticised for treating patients with less 
severe disorders that responds to short-term treatment, and especially cognitive treatment, in 
a better way than patients with more severe pathology (Abbass et al., 2008; Svartberg et al., 
2004). Systematic knowledge about patient characteristics predicting the duration of long-
term psychotherapy is largely absent, but Perry and colleagues (Perry et al., 2007) found in 
a recent study that dysthymic disorder, presence of any PD (particularly dependent PD), 
emotional neglect in childhood, and higher adaptive defence style predicted a greater 
number of sessions, while obsessive compulsive PD predicted fewer sessions. Even though 
our data showed that patients ending treatment before 18 months showed no more change 
than the patients still in treatment, one cannot simply assume that long-term treatment is 
needed for all patients with chronic disorders. Emerging questions might be how long is 
long-term treatment, and if short-term treatment may be adequate for some patients. These 
are empirical questions taking into account differences in severity of the disorder, type of 
diagnoses, and theoretical and practical development in the field.  
Regarding the issue of alliance it can be assumed that the initial day hospital treatment 
increases the possibility for making a robust alliance as the day hospital treatment offers 
multiple arenas for containing the patients’ interpersonal problems and early insecure 
attachment experiences. Increased number of therapists and patients are available for 
positive alliances, and teamwork among the therapists may reduce acting out 
countertransference feelings in the staff. Additionally, the patient’s negative transference 
may be diluted. Also, the patients in CP experienced a break in therapeutic modalities from 
the initial 18 weeks treatment to the following treatment where the patients were confronted 
with the challenges of both separation and forming new attachment relationships. The OIP 
patients had the benefit of continuing their treatment with the same therapist, and not being 
influenced by complicated group dynamics. These other patients can also represent a source 
of support, comfort and identification. The attrition rate was not significantly different in the 
two treatments, but one may speculate if some of the patients in OIP may leave treatment 
and then resume treatment after a while. A treatment model, intermittent therapy, with more 
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tolerant boundaries regarding attrition has been suggested as an alternative model for 
patients with insecure attachment (Paris, 2007). Intermittent therapy is independent of any 
specific method of therapy, and involves low-frequency follow-up and support after a period 
of regular and consistent treatment (Paris, 2007). Intermittent therapy could be important in 
the way that therapists need to consider whether partial improvement can be considered 
“good enough”. There is no standard for mental health, and by giving the patients sufficient 
space for “acting out” and ending therapy, or by the therapist offering a break, patients 
might try out something in real life with the confidence that they can come back into 
therapy when needed. The discussion regarding degree of structured treatment versus the 
ability to individually monitor the patients’ progress needs further analysis. 
In paper II the question regarding possible benefits for subgroups of patients were explored, 
but the size of the sample and the limited number of certain PDs prevented further 
exploration. We suggest that future studies also include exploration of individual change 
patterns, and nonlinear development.  
The final topic to be raised is the quality of the treatments. For the follow-up conjoint 
individual and group treatment in CP the therapists have been interviewed about their 
experience of the conjoint treatment model, but these data has not yet been analysed. 
Anyhow, the general attitude seems to have been positive, and the therapists have expressed 
satisfaction with being part of a psychotherapy research project working within firm 
boundaries and structures, and not being stuck with difficult patients on their own. Typical 
difficulties have been tendencies to postpone meetings between the group and individual 
therapists, despite clear instructions, as well as difficulties in acknowledging the differences 
between one-modality treatment and conjoint treatment with regard to engaging patients in 
the dual work. The data obtained from this study suggest that the conjoint treatment model 
for this sample of PD patients does not seem superior to individual treatment alone, but the 
study should be replicated before any firm conclusions are drawn.  
Health utilization costs 
The main finding from this study as reported in paper IV was that treatment costs were 
higher, and additional costs were significantly lower in CP than in OIP during the first 8 
months. The lowered additional costs in CP persisted at the 18 months follow-up resulting 
in equal total costs for the structured and extensive day hospital treatment followed by 
combined treatment as for the individual outpatient treatment when additional costs were 
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included in the calculations. Although the sample was small and highly skewed with the 
methodological and statistical limitations already discussed, these results are intriguing. Not 
only was the total costs for patients in the two treatments equal, but the total cost per month 
at 18 months follow-up were almost equal with the costs 12 months prior to treatment. If 
taking these calculations literally, it would mean that for this PD patient population 
extensive treatment is not more costly for the society than sporadic, unstructured treatment 
as was the pattern prior to the inclusion in the UPP.  
In comparing alternative treatments for patients with PDs (as in our study), the approach 
that require less investment of time and resources would usually be preferred if the efficacy 
is similar. An alternative approach would be to see health service utilization costs as adding 
information to the results. This approach is grounded on an earlier study suggesting that day 
hospital treatment offer adequate containing capacity compared to inpatient treatment for 
patients with PDs (Karterud et al., 1992). They judged containing capacity by the frequency 
of dropouts, suicides, suicide attempts, frequency of psychotic breakdowns and level of 
medication. One could argue that health utilization costs is an indirect measure of 
containing capacity, and hypothesise that structured treatment, as CP, would offer a 
heightened containing capacity compared to a less structured treatment, as OIP. This might 
indicate a heightened containing capacity in the initial day hospital treatment.  
The continuing decrease in use of additional services in CP is counter to the hypothesis of 
patient regression or patients forming an identity as hospitalised for these patients. In 
addition, the decrease might indicate a change in the patients which the clinical assessments 
were not able to capture. The methodological limitations make these reflections only 
suggestive, and the results certainly need to be replicated. The skewness in the use of health 
services indicates subgroups that use a lot more health services than other patients (20% of 
the patients used 85% of the total costs before inclusion in the project). If health utilization 
costs are a valid indicator of containing capacity, one might hypothesise that the need for 
containing capacity may be an indication of the choice of treatment modality for patients 
with PDs. The forthcoming evaluations of this sample of PD patients could answer some of 
these questions, and it will be interesting to follow the progress in the years to come. In 
addition, further studies are needed to explore these issues. Such studies should comprise 
large enough samples to perform subgroup analysis. 
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6. Conclusions and future directions 
The cross-national validity study of the Norwegian version of the SIPP-118 showed 
adequate psychometric properties at the facet level and seems promising as a measure of PD 
core pathology. Future studies should include investigation of the instruments ability to 
distinguish between axis I and axis II pathology and its sensitivity to change.  
The main findings in the two efficacy studies showed that at both 8 months follow-up and 
18 months follow-up there were no differences between CP and OIP on clinical variables. 
This finding challenges the notion that extensive and structured day hospital treatment 
models followed by group and individual outpatient treatment are more efficient than 
outpatient individual treatment for patients with PDs. The limited analysis of sub groups 
showed no indication that the initial day hospital treatment was better for the most severely 
disturbed patients. Even though both internal and external validity was considered 
satisfactory regarding the efficacy studies, one should of course be cautious making health 
political inferences solely on this study. The studies should be replicated at different sites 
and in larger samples that make extended analyses of subgroups possible. The research 
should be supplemented with process studies exploring individual and non-linear changes, 
as well as predictors of change. 
There was no difference in total costs for patients in CP and OIP at 18 months follow-up. 
The higher treatment costs in CP were compensated by a reduction in the use of additional 
health services. Future studies should comprise larger samples of patients and explore the 
differences between high cost patients and low cost patients. In addition, implementation of 
standardised measures makes it possible to compare costs across studies and diagnostic 
categories. Cost-benefit studies are to be preferred.  
Even if there are obvious limitations in an extensive study such as the UPP, the results from 
this study underline the importance of carrying out such studies. The questions concerning 
different modalities for treatment for various degrees of severity and the different PD 
diagnoses, and the generalizability to clinical work at the psychiatric health centres favours 
a study design combining RCT design with a naturalistic approach. The upcoming 36 
months evaluation of patient change and the process studies within the UPP will extend the 
presented results and bring knowledge into the field of day hospital treatment and general 
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PD treatment leading to a possibility for offering better treatment for the patients in need of 
help. 
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